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ABSTRACT

ENDOCANNABINOID MODULATION OF SPATIAL MEMORY IN AVERSIVELY
AND APPETITIVELY MOTIVATED BARNES MAZE TASKS
By John Pinckney Harloe III, B.A., M.S.
A Dissertation submitted in partial fulfillment of the requirement for the degree of Doctor
of Philosophy, at Virginia Commonwealth University
Virginia Commonwealth University, 2008
Major Director: Aron H. Lichtman, Ph.D.
Associate Professor, Department of Pharmacology and Toxicology

Genetic deletion or pharmacological blockade of the CB1 receptor has been
reported to impair extinction learning in aversive conditioning (i.e., conditioned fear and
Morris water maze) paradigms, but not in operant procedures in which food
reinforcement is earned. It is difficult to discern whether the differential effects caused
by CB1 receptor disruption on extinction result from the hedonics (i.e., aversive vs.
appetitive) or is related to the required responses associated with these disparate tasks. In
order to evaluate whether the hedonics is the determining factor, we used either aversive
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(i.e., escape from bright lights and air turbulence) or appetitive (i.e., to gain access to
water) motivators in the Barnes maze task, a model in which mice are required to enter a
hidden goal box. Administration of the CB1 receptor antagonist, rimonabant, disrupted
extinction learning under aversive conditions, but not under appetitive conditions. This is
the first study to show a differential effect of rimonabant on extinction in a task that
required identical motor behaviors, but only differed in hedonic nature of the reinforcer.
In addition, genetic ablation of CB1 receptor signaling impaired acquisition of the task
under both aversive and appetitive conditioning procedures. Conversely, enhancing
endocannabinoid signaling, via genetic deletion of the FAAH enzyme, accelerated
acquisition of the task under aversive, but not appetitive, conditioning procedures.
Accordingly, these data strongly support the hypothesis that the endogenous cannabinoid
system plays a necessary role in the extinction of aversively motivated behaviors, but is
expendable in appetitively motivated behaviors. While these findings underscore
concerns over potential side effects associated with CB1 receptor antagonists, they also
suggest that stimulating the endogenous cannabinoid system may be a pharmacological
approach to treat maladaptive behaviors that arise from stress or trauma.

INTRODUCTION

THE ENDOCANNABINOID SYSTEM

“Numerous observers have described the Indian hemp as producing in the
natives of the East, who familiarly use it instead of intoxicating spirits,
sometimes a heavy, lazy state of agreeable reverie, from which the
individual may be easily roused to discharge of any simple duty –
sometimes a cheerful, active state of inebriation causing him to dance,
sing and laugh, provoking the venereal appetitive, and increasing the
desire for food – and sometimes a quarrelsome drunkenness, leading to
acts of violence. During this condition pain is assuaged and spasm
arrested….On the whole, it is a remedy which deserves a more extensive
inquiry than any hitherto instituted.” (Christison, 1848)
Documented use of marijuana as a therapeutic spans thousands of years, treating
an unparalleled range of general [e.g. pain, edema, migraines] and specific [e.g. infantile
convulsions, hemorrhoids, malaria, sexual dysfunction] afflictions. In spite of its
intriguing history of medical use, European physicians such as O’Shaughnessy,
Christison, and Aubert-Roche began documenting side effects, such as cognitive
disruption, subjective effects, and anxiety (Christison, 1848). Eventually, these reports
would shift public opinion of marijuana to that of an intoxicant following the 20th
century. This shift in public attitude regarding marijuana, from therapeutic to intoxicant,
would eventually spread around the world, and in the United States, resulted in the
federal anti-marihuana act of 1937 and its classification as a controlled substance
1
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(National Commission on Marihuana and Drug Abuse, 1972). Despite its legal status
being restricted in most western countries, the prolonged debate over potential medical
utilization has continued. Inexplicably, the therapeutic potential of manipulating the
system marijuana activates, as an alternative to cannabis use, rarely enters the public
debate.
The discovery of delta-9-tetrahydrocannabinol (THC) as the primary active
constituent of marijuana (Gaoni and Mechoulam, 1964) opened the door for scientific
investigation into what is currently referred to as the endocannabinoid system. The
system is comprised of THC’s primary sites of action, the CB1 (Matsuda et al., 1990) and
CB2 receptors (Munro et al., 1993), as well as THC’s endogenous counterparts, the
endocannabinoids. This class of THC-like compounds, distinguished by their activity at
the CB1 and CB2 receptors, include anandamide [AEA] (Devane et al., 1992), 2arachidonoylglycerol [2-AG] (Mechoulam et al., 1995; Sugiura et al., 1995), noladin
ether (Hanus et al., 2001), virodhamine (Porter et al., 2002), and Narachidonoyldopamine (Huang et al., 2002). Enzymes responsible for the inactivation of
the two primary endocannabinoids, anandamide and 2-AG, are respectively fatty acid
amide hydrolase [FAAH] (Cravatt et al., 1996) and monoacylglycerol lipase [MAGL]
(Dinh et al., 2002).
Unlike the vast majority of traditional neurotransmitters (e.g., dopamine,
acetylcholine), endocannabinoids such as anandamide and 2-AG are not stored in
vesicles, but are synthesized and released ‘on demand’ from membrane bound precursors
(Di Marzo et al., 1994). The biosynthesis of anandamide occurs through multiple
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pathways, common to each is the formation of the precursor N-arachidonoylphosphatidylethanolamine (NAPE). The enzyme N-acyl transferase (NAT), catalyzes the
transfer of arachidonic acid from phosphatidylcholine (PC) to phosphatidylethanolamine
(PE), resulting in the formation of NAPE. Previous research in rat cortical neurons has
implicated the involvement of two intracellular second messengers controlling NAT
activity: Ca2+ and cyclic AMP (cAMP). While cAMP is thought to enhance the activity
of NAT via protein kinase A-dependent phosphorylation, evidence for calciumdependence is supported by the observation that NAT is inactive in the absence of Ca2+
(Cadas et al., 1996). Three different pathways have been identified through which NAPE
is converted into AEA. First, PLC catalyzes the formation of the intermediary p-AEA,
which is subsequently converted into AEA by phosphatases. Alternatively, anandamide
can be produced by NAPE-PLD. However, this pathway appears to be a ‘salvage
pathway,’ utilized when the PLC/phosphatase pathway is compromised (Schmid et al.,
1990; Cadas et al., 1997; Sugiura et al., 2002; Sugiura and Waku, 2002; Leung et al.,
2006; Liu et al., 2006; Gomez-Ruiz et al., 2007; Liu et al., 2008). Finally, conversion of
NAPE, by sPLA2/Abhd4, to lysoNAPE, which can be subsequently converted into AEA
by Lyso-PLD. Inactivation of anandamide is primary mediated by the enzyme FAAH,
producing arachidonic acid and ethanolamine. However, evidence also exists for cyclooxygenase-2, and lipo-oxygenase as enzymatic regulators of anandamide degredation
(Kozak and Marnett, 2002).
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The biosynthesis of 2-AG is thought to occur through two pathways,
distinguished by the formation of diacylglycerol (DAG). In the first, phospholipase C
(PLC) hydrolyzes phosphoinositides (PI) to produce DAG (Stella et al., 1997).
Alternatively, phosphatidic acid (PA) phosphohydrolase can hydrolyze PA to synthesize
DAG (Bisogno et al., 1999). Common to both pathways, DAG lipase then catalyzes
DAG hydrolysis to form the endocannabinoid 2-AG (Farooqui et al., 1989; Bisogno et
al., 2003). Mediating the metabolism of 2-AG are the enzymes monoacylglycerol lipase
(MGL) (Konrad et al., 1994), ABHD12, ABHD6 (Blankman et al., 2007), and FAAH (Di
Marzo et al., 1998). Collectively, MGL, ABHD12, and ABHD6 account for ~98% of 2AG hydrolysis [respectively: ~85%, 9% and 4%], indicating a negligible role for FAAH
(Blankman et al., 2007). Irrespective of the degrading enzyme, arachidonic acid and
glycerol are the products of 2-AG degradation (Di Marzo et al., 1999). Together, these
receptors, endogenous agonists, and the enzymes regulating them, comprise the
endocannabinoid system.
The CB1 receptor is one of the most abundant receptors in the CNS, exhibiting its
highest densities in the cerebellum, hippocampus, striatum, globus palladum, and
substantia nigra (Herkenham et al., 1991; Matsuda et al., 1993). The CB1 receptor, and
the predominantly peripheral CB2, belong to the seven trans-membrane receptor family of
G-protein-coupled receptors (GPCR). Interestingly, the CB1 receptor is the most
abundant GPCR found in the brain (Howlett et al., 1990; Herkenham et al., 1991).
Further classification of cannabinoid receptors puts them in the family of inhibitory
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GPCRs known as Gi/o. Activation of the cannabinoid receptors results in a cascade of
effects, beginning with the inhibition of adenylyl cyclase, subsequent decrease in cAMP,
and ensuing decrease in protein kinase A dependent phosphorylation (Devane et al.,
1988). Additionally, activation can produce inhibition of calcium through N (Mackie and
Hille, 1992), L (Gebremedhin et al., 1999), and P/Q type ion channels (Twitchell et al.,
1997) as well as activation of inwardly rectifying K channels. Collectively, the effects
serve to decrease neurotransmitter release, primarily through presynaptic inhibitory
processes (Mackie et al., 1995).

CANNABINOIDS AND COGNITION

The past 30 years have seen great strides in our understanding of how CB1
agonists affect learning and memory. However, these advances have not been easy, often
requiring novel approaches to address various inconsistencies or uncertainties.
Moreover, factors such as cognitive terminology hamper the interpretation and
extrapolation of data. For example, the terms learning, memory, performance, and
cognition are all related and at times employed interchangeably. Across academic fields,
however, these terms can have different definitions and connotations and can be devided
into numerous different cognitive processes. Further classification of memory includes
working (short-term) and reference (long-term) memory. A third category, recognition
memory, is based on an animal’s inherent desire to explore unfamiliar objects, scents, or
conspecifics (Wotjak, 2005). The inherent difficulty then, is that the investigator must
separate these different facets of cognition when designing an experiment to determine,
and accurately report, which aspect is affected.
To clarify the terminology used in this dissertation, memory is defined as changes
in an animal’s behavior some time after learning, and involves processes of acquisition,
consolidation and retrieval. Memory acquisition is defined as a learned response. For
6
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example, acquisition in contextual conditioned fear involves the association between a
context, and a shock. During consolidation, learned information is encoded into memory
by alterations in interneuronal communication, moving the memory from a labile, to a
more fixed state (Abel and Lattal, 2001). The persistence in these changes can then be
categorized by short-term and long-term memory based on the duration of memory
retention, and biosynthetic changes in memory consolidation (McGaugh, 2000). Upon
reintroduction into the conditioning context, the previously learned association (memory)
is retrieved, and results in behavioral alterations. In the example of contextual fear
conditioning, reintroduction into the conditioning context results in the retrieval of
memory associating prior experience in the context with shock, and is behaviorally
manifested as freezing behavior. The persistence of a memory is limited by either its
decay, or the inability to retrieve it. Conversely, the original memory may be actively
suppressed by an inhibitory learning process known as extinction learning (Wotjak,
2005).
While this is somewhat of a superficial overview of learning, it serves to
introduce a greater problem facing behavioral research. Varvel & Lichtman (2005)
provide a precise summary:
“…learning and memory is not directly measured, but is inferred based on
changes in performance. In particular alterations in attentional,
sensorimotor, and motivational processes can affect performance,
independently of cognition.”
Perhaps the greatest issue for the researcher is the inescapable reliance on
interpreting performance as a manifestation of learning. Bouton & Moody (2004)
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expertly discuss these issues in an enlightening review. Almost immediately, the authors
place emphasis on the central idea that ‘what an animal does in an…experiment is not the
same as what it knows.’ Learning, the authors continue, represents a hypothetical
psychological and physiological change within the brain and is a separate entity from
performance, the expression of learning through behavior (Bouton and Moody, 2004).
In the early 20th century, Edward Tolman was the first to illustrate the separation
of learning and performance. In their innovative experiment of latent learning, the
authors trained two groups of rats to navigate a maze; the first group was rewarded for
successful completion of the maze task, while the second was not. As might be expected,
rats rewarded for completing the task performed to a superior degree, committing fewer
errors than their non-rewarded counterparts. However, once the non-rewarded group
received reward for completing the task, their efficiency at completing the task increased
on the following trial. The authors concluded that even though the behavior of the nonreinforced group did not reflect learning, it was nonetheless taking place. Thus, the
function of reward was to motivate the animal to perform (Tolman and Honzik, 1930).
Summarized by Bouton & Moody (2004), ‘learning is not the same as performance.
Motivation is required for translation.’
Measuring learning independent of confounds including, emotional state, ambulatory
function, attentional state, and motivation are a primary concern for an investigator.
These variables represent a challenge to investigators in the field of cannabinoids, as
genetic and pharmacological manipulation of the endocannabinoid system can affect all
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of the above-mentioned processes, at times making it difficult to infer the occurrence of
learning. As will be discussed, controlling for non-mnemonic factors was a primary
consideration during the design of the studies presented in this dissertation.

BACKGROUND & SIGNIFICANCE

“For the Egyptians, hemp is the plant par excellence, not for the uses they
make of it in Europe and many other countries, but for its peculiar effects.
The hemp cultivated in Egypt is indeed intoxicating and narcotic.”
(Rouyer, 1810)
Marijuana use has long been associated with perturbations of working memory
that reflects adapting one’s behavior to new information (Varvel and Lichtman, 2005).
One of the predominant models for studying this task is the delayed non-match to sample
(DNMS) or the delayed match to sample (DMTS) operant task. These experiments rely
on the subject’s ability to remember a stimulus (e.g. previous choice) over a variable
delay, an increase in which requires a greater demand on working memory. Typically,
the paradigm involves the presentation of a sample stimulus, followed by a delay in
absence of the stimulus. Following the delay, subjects are exposed to both the sample
stimulus and a novel stimulus. The task requires that the subject makes an active
response, (e.g., a lever press), indicating the novel-stimulus (DNMS) or the previously
exhibited sample stimulus (DMTS) for reward. Based on the correct percentage of
responses, THC (2mg/kg) administration delay-dependently impaired performance,
resulting in performance indistinguishable from hippocampally-lesioned rats pre-trained
in the task (Hampson and Deadwyler, 1998; Deadwyler et al., 2007).

10
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Results from a two-component operant task in rats provides further evidence for
THC disrupting working memory (Mallet and Beninger, 1998). In this experiment,
subjects pressed one of two levers, depending on the presence of two different stimuli
(cued conditional discrimination component). Training prior to drug administration
allowed subjects to learn to make the correct choice on all subsequent trials. By
definition, in trained animals, this component requires reference memory as the subjects
had already learned the task (Honig, 1978). In the second component of the session
(delayed non-match to position), no cues were presented and rats were required to press
the lever opposite the one pressed during the first component. Even after learning this
new rule, greater-than-chance responding could only be achieved by remembering which
of the two levers was pressed during the first component of that particular trial. By
definition, this component requires working memory (Honig, 1978). THC, as well as
anandamide co-administered with the non-specific amidase inhibitor
phenylmethylsulfonyl fluoride (PMSF), disrupted the working memory aspect, but left
reference memory intact. Consistent with a CB1 receptor mechanism of action,
administration of the CB1 antagonist, rimonabant, reversed the performance deficits
caused by exogenously administered CB1 agonists.
In addition to impairing memory in operant tasks, THC impairs learning in spatial
memory paradigms, which generally rely on the use of spatial cues in the environment to
navigate a maze. Performance in these paradigms requires hippocampal-dependent
processes, an area characterized by dense CB1 receptor localization, as well as taking

12
advantage of an animal’s natural tendencies such as foraging or predator avoidance
(Olton, 1987; Lichtman et al., 2002). For example, THC dose-dependently disrupts
performance in the 8-arm radial arm maze. During acquisition of the task, rats use spatial
cues to find food in all but one of the arms. Subjects then must remember the unexplored
arm on a subsequent exposure following a temporal delay. The dependent measure,
errors prior to entering the correct arm, assesses performance. Lichtman et al., (1995)
demonstrated that systemic administration of THC disrupted performance as assessed by
the increased number of errors committed. In a follow-up study THC’s disruptive effect
was exhibited as delay-dependent, and dose-dependently reversed by rimonabant
administration (Lichtman and Martin, 1996).
Another commonly used method of assessing spatial memory is the Morris water
maze, a task requiring subjects to use spatial cues to locate and swim to a hidden
platform. THC administration disrupted performance in a working memory version of
this task, where the location of the hidden platform is variable, exhibited by longer path
lengths and latencies to locate the hidden platform. THC also disrupted a reference
memory version of the task, in which the hidden platform location was consistent across
trials. However, the disruptive effects occurred at much higher doses (100 mg/kg) when
compared to the working memory model (3 mg/kg), suggesting an increased
susceptibility to THC’s disruptive effects in working memory compared to reference
memory (Varvel et al., 2001).
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Studies utilizing exogenous cannabinoid administration provide rationale for the
involvement of the endogenous cannabinoid (eCB) system in cognitive processes, but
cannot closely mimic the actions of an endogenous system firmly integrated in neural
circuits and eliciting precise biochemical responses to specific contexts (Varvel and
Lichtman, 2005). Moreover, confounding the interpretation of the data are side effects
associated with exogenous administration of CB1 agonists, such as alterations in motor
behavior and motivation. The development of genetic and pharmacological tools specific
to endogenous CB1 receptor signaling have provided alternative means to study the eCB
system. The following section is designed to review the literature surrounding the use of
these tools, as well as their effects on acquisition and extinction learning. Moreover, the
focus is specific to the work presented in this dissertation, exploring acquisition and
extinction following pharmacological CB1 receptor antagonism, as well as acquisition
effects associated with the deletion of the CB1 receptor and FAAH enzyme.

THE eCB SYSTEM AND ACQUISITION

RIMONABANT

The CB1 receptor antagonist/inverse agonist, rimonabant, has been a highly useful
tool to investigate the endocannabinoid system (Rinaldi-Carmona et al., 1994). As a
pharmacotherapeutic, rimonabant has shown potential for treating multiple disorders.
Clinical trials revealed its utility in treating type 2 diabetes, increasing HDL-LDL ratios,
and reducing risk factors associated with cardiovascular disease (Despres et al., 2005;
Van Gaal et al., 2005; Pi-Sunyer et al., 2006; Scheen et al., 2006). Likewise, published
research has shown its value as a possible pharmacotherapeutic for treating dependence
associated with ethanol (Arnone et al., 1997), tobacco (Cahill and Ussher, 2007) opiates
(Navarro et al., 2001), cocaine (De Vries et al., 2001), and cannabis (Tanda et al., 2000;
Justinova et al., 2005).
Currently under the trade name Acomplia® (Zimulti® in the United States),
rimonabant has won approval for the treatment of obesity in the European Union, and is
marketed in countries including Argentina, Austria, Denmark, Finland, Germany, Ireland,
Norway, Sweden, Greece, Brazil, Mexico, and the United Kingdom. Conversely, in the
United States an FDA advisory panel (2007) composed of outside experts voted
unanimously in favor of rejecting approval citing inadequate safety data. More recently,
14
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the possibility of FDA approval for rimonabant was dealt a severe setback following the
release of data from a meta-analysis of four clinical trials. In their study, the authors
reported a 40% increase in adverse events ranging from depression and anxiety to
suicidal thoughts, despite the exclusion of patients with a history of depression or
psychiatric illnesses during clinical trials (Christensen et al., 2007). Currently, it would
appear that sales within the United States might never materialize. Nonetheless,
rimonabant remains a useful pharmacological tool to investigate cannabinoid receptor
agonists as well as the eCB system.
In rodent models of learning and memory, rimonabant exhibits a spectrum of
cognitive effects; improving, disrupting, and at times exhibiting no effect on learning.
Terranova et al., (1996) published the first report showing that rimonabant administration
enhanced memory in a social recognition paradigm. In this paradigm, the amount of time
a mature mouse spent investigating a juvenile conspecific during their first meeting vs.
follow-up meetings, measures ‘remembering.’ Thus, decreased time spent investigating
on the second exposure to the juvenile would indicate that they remembered the first
exposure. In this paradigm, rimonabant administration 5 min after the first exposure, but
not 15 or 90 min after, decreased the time spent investigating during the second exposure.
Given the narrow window in which rimonabant administration improved memory
functions, the data would suggest an enhancement of consolidation (Terranova et al.,
1996).
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Reports from the radial arm maze task further support rimonabant enhancing
memory processes. In the acquisition of this procedure, rats have access to seven of the
eight arms. In the test phase six hours later, errors prior to entering the remaining arm
provide a measure of how well the subject remembered. Rimonabant administration
prior to the first acquisition phase, but not after the first phase or 20-min before the test
phase, decreased the number of re-entry errors (Lichtman, 2000; Wise et al., 2007). In a
similar radial arm maze task, rimonabant was observed to dose-dependently decrease reentry errors when administered immediately after the acquisition phase, but not before
the test phase (Wolff and Leander, 2003). Possible explanations for differential results
when administration of rimonabant occurred after the test phase include differences in
procedure (blocking one vs. four arms), or the choice of vehicle. Alternatively, when
administered after the test phase, the absence of enhanced acquisition may be a result of
the drug failing to absorb quickly enough to affect consolidation, or a critical period in
which consolidation processes are active.
Similarly, rimonabant administration before or immediately after the acquisition
phase, but not the test phase, enhances avoidance behavior in the elevated T-Maze
(Takahashi et al., 2005), and intrahippocampal administration prior to training enhances
memory in food-storing birds for the location of hidden food rewards (Shiflett et al.,
2004). Collectively, the results from procedures associating enhanced acquisition with
rimonabant suggest the drug is acting on, and improving, the acquisition and/or
consolidation of memory rather than retrieval.
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Procedural differences appear to provide a possible explanation for reports in
which rimonabant administration fails to affect acquisition of other tasks. For example,
rimonabant administration does not affect acquisition rates in the Morris water maze
spatial memory task (Varvel et al., 2005), passive avoidance tasks (Mazzola et al., 2003;
Niyuhire et al., 2007), operant conditioning (Mallet and Beninger, 1998; Niyuhire et al.,
2007), or conditioned fear (Marsicano et al., 2002; Suzuki et al., 2004; Kamprath et al.,
2006; Niyuhire et al., 2007) paradigms. The collective literature regarding cognitive
alterations following rimonabant administration supports two conclusions. First,
rimonabant enhances acquisition and/or consolidation of memory, but does not affect
retrieval. Second, procedural components appear critical in determining the absence or
expression of rimonabant’s effects. Specifically the temporal components, but not the
hedonic nature of the reinforcer, may be primary. Thus, tasks demanding memory
processes lasting for minutes to hours show enhancement, while those on the order of
seconds, do not (Lichtman et al., 2002). However, this explanation appears insufficient
as rimonabant has been shown to enhance performance in a delayed non-match to sample
paradigm. At delays longer than 10s, rimonabant administration resulted in a greater
percentage of correct responses, as well as increasing the frequency of ‘strong’ SmR code
strength, a measure of hippocampal information encoding at the time of sample
responding during DNMS trials. Furthermore, rimonabant impaired acquisition of delay
eyeblink conditioning (Kishimoto and Kano, 2006). In this study, the conditioned
stimulus (tone) co-terminates with the unconditioned stimulus (shock), and the learned
association between US and CS results in a conditioned startle response (eyeblink) during
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subsequent CS presentations. During acquisition of the task, rimonabant treated subjects
exhibited a significant reduction in the percentage of conditioned responses compared to
vehicle treatment. However, indistinguishable performance occurred between treatment
groups during the first acquisition day, and acquisition differences between groups were
not observed until subsequent acquisition trials had been performed. Thus, the relevance
of these data, with respect to the hypothesis of Lichtman et al., (2002), is undetermined.

CB1 -/- MICE

Converging evidence provided by genetic correlates of pharmacological
antagonism provide an alternative means of verifying results from pharmacological
studies by inactivating specific biological processes genetically. Furthermore, utilizing
both genetic and pharmacological approaches provides evidence that results are
independent of confounds associated with drug administration (e.g., inverse agonism,
non-specific effects, interactions, alternative sites of action) and/or genetic knockout
animals (i.e., compensatory mechanisms, genetic drift, downstream developmental
changes). To this end, CB1 receptor knockout mice provide a complementary approach
along with the use of CB1 receptor antagonists to block eCB signaling. Reibaud et al.,
(1999) were the first to show enhanced acquisition in CB1 -/- mice during a two-trial
object recognition task. In this experiment, mice received a ten-min open field trial in
the presence of a novel object. Following a 3, 24, or 48 h delay, subjects were reexposed in the presence of both the familiar, as well as a new, unfamiliar object.
Comparing the amount of time spent investigating each object provides a measure for
how well the subject ‘remembers’ the first encounter, and chance occurrence is set at
50%. Following a 3 h delay, both genotypes exhibited an indistinguishable increase in
time spent analyzing the new object compared to the familiar object. However, 24 and
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48 h delays resulted in chance performance in wild-type mice, while CB1 -/- mice
continued to show preference for investigating the unfamiliar object. These results were
later replicated using CB1 -/- mice on the CD-1 background (Maccarrone et al., 2002), in
both old and young mice. While the effect was repeated in both young and old knockout
mice, the authors reported age-related adaptive changes in knockout mice. Specifically,
deletion of the CB1 receptor resulted in an age-related increase in FAAH activity, and
subsequent decrease in AEA content. Furthermore, in both cases these changes exhibited
the most profound alterations in the hippocampus.
Evidence for improved acquisition in CB1 -/- mice has also been exhibited in an
active avoidance test (Martin et al., 2002). In this paradigm, the subject is placed in an
apparatus composed of two chambers connected by a door. The subject must learn that
the onset of a light is predictive of an impending shock, and avoiding the shock requires
charging into the unlit compartment. While both genotypes exhibited similar baseline
performance on day one, CB1 -/- mice showed a significant enhancement of avoidance
learning, demarcated by increased conditioned charges compared to wild-type mice.
Converging electrophysiological evidence provides further support for enhanced
acquisition in CB1 -/- mice. Long-term potentiation (LTP) is thought to underlie the
formation of memory by strengthening synaptic connections following repeated
stimulation of a synaptic pathway. In vitro analysis of hippocampal CB1 -/- brain slices
reveals an enhanced capacity to strengthen synaptic connections, resulting in an almost
50% greater response compared to wild-type controls (Bohme et al., 2000).
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Under certain conditions, CB1 -/- mice exhibit impaired acquisition. In models of
cued conditioned fear, subjects learn to associate the onset of a cue with impending
shock. Following repeated pairings, analysis of freezing behavior in probe trials where
the cue is presented in a new context denotes acquisition of the task. In this paradigm,
genetic ablation of the CB1 receptor leaves acquisition unaffected (Marsicano et al.,
2002; Cannich et al., 2004; Kamprath and Wotjak, 2004). Similarly, contextual
conditioned fear involves testing the subject in the same context as training. Unlike
results from the cued procedure, CB1 -/-, but not CB1 +/+, mice on the CD-1 background
exhibited very little freezing upon re-exposure to the context, resembling results from
unshocked CB1 -/- and +/+ control mice (Mikics et al., 2006). While the strain
differences may have influenced the results, differences in brain areas associated with the
two procedures may also account for the disparity in results. Lesions of the amygdala
impair cue-induced fear, while lesions of the hippocampus impair context-induced fear
(Phillips and LeDoux, 1994; McNish et al., 1997; Bast et al., 2003; Ahi et al., 2004).
Cued conditioned fear is largely reliant on the amygdala, whereas contextual conditioned
fear is dependent on the dorsal hippocampus.
Conditioned eyeblink paradigms are categorized primarily by temporal
differences in the presentation of the unconditioned stimulus (US) and conditioned
stimulus (CS). Delay paradigms require US (shock) and CS (tone) co-termination,
whereas trace paradigms utilize a stimulus-free interval between US and CS presentation.
Whereas delay paradigms are dependent on the cerebellum (McCormick and Thompson,
1984; Thompson et al., 1997), trace conditioning requires both the cerebellum and
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hippocampus (Moyer et al., 1990; Weiss et al., 1999; Kishimoto et al., 2006).
Comparison of CB1 -/- and +/+ mice in the delay procedure reveals acquisition deficits in
-/-, but not +/+ mice (Kishimoto and Kano, 2006). Furthermore, electromyogram (EMG)
recordings on the final acquisition day revealed significantly lower average amplitudes in
response to the CS, presumably due to behavioral differences in conditioned responding.
Investigation into potential confounds revealed no significant genotype differences with
regards to spontaneous eyeblink frequency, motor coordination, startle responses, or the
intensity of the US to elicit an eyeblink response.

In opposition to the acquisition of the

delay conditioning paradigm, CB1 -/- and +/+ mice showed equal acquisition
performance in the trace conditioning procedure.
Recent reports underscore the importance of age as a determining factor when
studying the cognitive performance of CB1 -/- mice. Bilkei-Gorzo et al., (2005)
demonstrated that deletion of the CB1 receptor results in age-specific cognitive effects.
In the social recognition paradigm, subjects are exposed to a novel, juvenile conspecific
on two occasions separated by a variable interval. A decrease in time investigating the
partner on the second exposure is indicative of remembering. Young (6-7 weeks of age)
CB1 -/- mice exhibited enhanced acquisition compared to wild-type age-matched
controls. However, a striking decline in performance was observed in mature (3-5
months) CB1 -/- mice, exhibiting impairment similar to old (14-17 months) wild-type
mice. To determine if the observed effects were strain-dependent, the experiment was
replicated using juvenile and mature CB1 -/- and +/+ mice on the CD-1 background.
Again, young CB1 -/- exhibited enhanced retention compared to controls, as well as a
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rapid age-related decline in performance of CB1 -/- mice. Performance of the same
groups in an operant condition paradigm revealed a similar age-related decline in the
cognitive performance of CB1 -/- mice. Conversely, deficits in the wild-type group were
only observed in the old group, exhibiting impaired performance similar to mature CB1 /- mice. Analysis of neuronal density within the different age groups provides an
intriguing correlate to the behavioral deficits. Compared to wild-type mice, CB1 -/- mice
show a rapid decline in the density of hippocampal neurons as they age, in the most
extreme case exhibiting a 70% reduction in old knockout mice compared to their agematched controls.
The expression of cognitive differences in CB1 -/- mice appears to depend on the
hedonic nature of the reinforcer (e.g. aversive vs. appetitive). In an operant conditioning
procedure in which subjects were given food-reward for a correct nose-poke response of
an illuminated hole, CB1 -/- mice exhibited normal acquisition of the task (Holter et al.,
2005). Importantly, CB1 -/- mice showed reduced motivation to work for reward
following moderate food restriction. Increasing the level of deprivation proved necessary
to achieve equivalent performance between genotypes. Furthermore, the age of the mice
was the same as mature subjects from the experiment by Bilkei-Gorzo et al., (2005). As
this group reported an age-dependent decline in performance in a similar operant task,
effects observed by Holter et al., may be influenced by differences in cognitive ability.
Similar to the experiment by Holter et al., baseline differences in the acquisition
of an operant conditioning procedure were observed in CB1 -/- mice trained to nose-poke
for either corn oil or the sweetened reinforcer Ensure (Ward and Dykstra, 2005; Ward et
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al., 2007). Under either condition of reinforcement, both genotypes exhibited the ability
to acquire the task. However, regardless of the reinforcer used, fewer CB1 -/- mice
achieved maximal responding than their wild-type counterparts. Higher levels of
responding (e.g. active nose-poke hole responding) were observed during maintenance
sessions in wild-type mice compared to CB1 -/- mice trained to respond for Ensure, and
substitution of sweetened reward for the fat-reinforcer corn oil produced a similar
decrease in responding. As CB1 -/- mice primarily exhibited differences in responding,
rather than the acquisition of the task, the hedonic value of the different appetitive
rewards may account for observed genotype differences.
Results from the aversively conditioned Morris water maze spatial memory task
suggest acquisition differences between genotypes result from differences in procedure,
as genetic deletion of the CB1 receptor leaves spatial memory intact (Varvel and
Lichtman, 2002). Following repeated acquisition trials, the subject learns to use spatial
cues surrounding the maze to locate and swim to a hidden platform. In a fixed platform
protocol, where the location of the hidden platform is constant, both genotypes exhibited
similar latencies, as well as path lengths, to discover the target location. While both
genotypes displayed a similar overall reduction in thigmotaxia by the end of acquisition
training, the decrease occurred more gradually in knockout mice than in wild-type mice.
The possibility of an anxiogenic phenotype was further supported by the observation that
one-half of the CB1 -/- mice stopped swimming in favor of floating, in some cases
requiring rescue to prevent sinking. Working memory was also assessed by shifting the
platform to a new location each acquisition day. Again, both genotypes showed similar
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ability to acquire the task, however notable phenotypic differences were observed. CB1 /- mice performed with a pronounced inconsistency, resulting in the removal of 50% of
the subjects for failing to reach criteria. In extreme cases, seizures, and eventual death,
occurred in five of the mice. Furthermore, the authors reported reduced body weights,
labored swimming, and dysfunctional search strategies (i.e., swimming in circles).
Importantly, the observed differences were absent in wild-type mice.
In a follow-up experiment by the same group, CB1 -/- showed no differences in
acquiring a fixed-platform task compared to wild-types (Varvel et al., 2005). While the
authors did not report genotype differences in thigmotaxia, alternative evidence for an
anxiogenic phenotype was reported when non-contingent swimming was assessed. In
this experiment, naive subjects were exposed to the maze in the absence of an escape
platform during massed probe trials. Across trials, a gradual reduction in swim speed
was observed in wild-type, but not CB1 -/- mice. Thus, it would appear that while spatial
memory is intact, differences in experimental design may produce cognitively unrelated
effects arising from a possible anxiogenic phenotype.

FAAH -/- MICE

The recent genesis of mice lacking the gene for the FAAH enzyme provides a
useful model for studying enhanced eCB signaling by inhibiting the metabolism of
anandamide (Cravatt et al., 2001). Varvel et al., (2006) were the first to report
acquisition differences in FAAH -/- mice, compared to their wild-type controls in the
Morris water maze spatial memory task. During acquisition of a fixed platform
procedure, both genotypes exhibited similar acquisition profiles, measured by escape
latency, and the corresponding path length. Conversely, in a working memory paradigm
where the location of the hidden platform was placed in a new location each day, FAAH /- mice acquired the task significantly faster than their wild-type littermates. Of interest,
the authors note a non-significant trend (p=.06) of enhanced acquisition within the first
acquisition day.
In a follow-up experiment by the same group, FAAH -/- mice exhibited enhanced
acquisition of a fixed-platform task (Varvel et al., 2007). As these data are in contrast to
results from the previous experiment, procedural differences may have accounted for the
disparate nature of the results. In the previous experiment, the hidden platform was
placed arbitrarily towards the front of the tank (i.e. closest to the entrance to the
enclosure). Conversely, the current experiment placed the hidden platform in the back of
26

27
the tank (i.e. furthest from the entrance to the enclosure). Apparently, wild type mice
display a steeper acquisition curve when the platform is placed in the front aspect of the
tank than in the back of the tank. Thus, placing the hidden platform in the back of the
tank unmasked phenotypic differences.

RIMONABANT AND EXTINCTION LEARNING

Extinction is the suppression of a previously learned behavior, following nonreinforced trials. Disruption of CB1 receptor signaling has been shown to impair
extinction learning in aversively reinforced models of conditioned freezing (Marsicano et
al., 2002; Suzuki et al., 2004; Niyuhire et al., 2007), passive avoidance (Niyuhire et al.,
2007), and spatial memory (Varvel et al., 2005). In the cued conditioned fear paradigm,
a subject learns that a tone is predictive of an impending footshock. With each
successive tone presentation in the absence of a footshock, the percentage of time spent
immobile decreases, demarcating the occurrence of extinction learning. Marsicano et al.,
(2002) were the first to show that administration of rimonabant prior to extinction trials
resulted in a perseverance of freezing behavior, while vehicle treated subjects exhibited a
gradual reduction in freezing behavior following repeated extinction trials. Similarly, in
the Morris water maze spatial memory task, mice learn to swim to a hidden platform
during acquisition trials. Following removal of the platform during extinction trials,
subjects gradually decrease the amount of time spent in the quadrant that previously
contained the hidden platform. Thus, while vehicle-treated mice increasingly search
other areas of the maze across extinction trials, rimonabant treated animals continue to
perseverate in the irrelevant quadrant (Varvel et al., 2005). Interestingly, in the water
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maze, the disruption of extinction was only seen when weekly, but not massed (multiple
probes separated by a short temporal delay), extinction trials were administered,
suggesting temporal components of the task may be critical. Finally, in the passive
avoidance paradigm subjects learn to associate shock with one of two chambers.
Following conditioning, daily extinction trials are administered and the latency to enter
the chamber associated with shock is recorded. In vehicle-treated animals, subjects
exhibited a gradual reduction in the latency to enter the chamber associated with shock
across extinction sessions. Conversely, subjects administered rimonabant exhibited
consistently elevated latencies across trials (Niyuhire et al., 2007).
There is evidence that rimonabant does not affect extinction learning in
appetitively reinforced tasks. For example, rimonabant administration did not affect
extinction of operant conditioning, either in daily or weekly trials (Niyuhire et al., 2007).
Importantly, the results by Niyuhire et al., (2007) are in agreement with a previous
operant conditioning study using CB1 -/- mice trained to nose poke for food reward
(Holter et al., 2005). Collectively, these results support the hypothesis that the nature of
the reinforcer (e.g. aversive vs. appetitive) is primarily responsible for the expression of
disrupted extinction in models of attenuated CB1 receptor signaling (Holter et al., 2005).

SUMMARY

An underlying theme in the review presented above is the inherent difficulty in
comparing results from qualitatively different behavioral tasks. As the models discussed
in the review fluctuate primarily on either the source of reinforcement (i.e. appetitive vs.
aversive), or behavioral demands (i.e. learning to lever-press or find a hidden goal), the
necessity for a paradigm in which either is controlled is apparent. The recent adaptation
of the Barnes maze for use in mice presents the unique possibility of using dissimilar
sources of reinforcement to motivate learning the same goal. If validated, utilization of a
modified Barnes maze would facilitate addressing three outstanding questions in the
literature.
First, the specific conditions in which rimonabant affects extinction learning have
yet to be determined, but appear to depend on whether the behavior is learned in an
appetitive or aversive task (Holter et al., 2005; Niyuhire et al., 2007). However, there
are two outstanding issues with the latter hypothesis. First, rimonabant may produce a
decrease in hedonic value of the reward used in both studies (food pellet or sweetened
milk). Previous research has shown that rimonabant, and CB1 receptor deletion,
decreases food consumption (Kirkham and Williams, 2001), salience of food reward
(Ward and Dykstra, 2005), and preference for sweetened foods (Arnone et al., 1997;
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Higgs et al., 2003). Predictably, CB1 -/- mice required a greater level of food restriction
to reach asymptotic acquisition performance as wild-type littermates (Holter et al., 2005).
Again, the difficult nature of resolving differences in hedonics (i.e. aversive vs.
appetitive) and the disparate behavioral demands of the tasks preclude interpretation.
Second, many reports suggest genetic deletion of the CB1 receptor affects
acquisition learning. However, conflicting reports exist regarding how acquisition is
affected (i.e. facilitated, impaired, or unaffected), and under what reinforcement
conditions. For example, CB1 -/- mice have exhibited a broad spectrum of acquisition
effects in aversively reinforced paradigms. Genetic disruption of CB1 receptor signaling
enhances acquisition of an active avoidance paradigm (Martin et al., 2002); impairs
learning of contextual conditioned fear sometimes (Mikics et al., 2006), but not always
(Suzuki et al., 2004), and delay eyeblink conditioning (Kishimoto and Kano, 2006); but
does not affect spatial memory (Varvel and Lichtman, 2002; Varvel et al., 2005), cued
conditioned fear (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006), or
trace eyeblink conditioning (Kishimoto and Kano, 2006). Appetitively reinforced
models suggest acquisition is intact following CB1 receptor deletion. Bilkei-Gorzo et al.,
(2005), were the first to report intact acquisition of an operant conditioning procedure in
young (6-7 weeks of age) CB1 -/- mice compared to age-matched controls. In agreement
with these results, deficits in acquisition learning were not reported in operant
conditioning experiments utilizing mature CB1 -/- and +/+ mice trained to nose-poke for
food pellets (Holter et al., 2005), Ensure (a sweetened protein drink), or corn-oil (Ward et
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al 2007; Ward, personal communication, 2007). An important caveat of these studies is
the increased level of food deprivation in the knockout mice to increase their motivation
to work for food reward. Thus, similar acquisition profiles in a task where behavioral
demands are constant, and only the source of reinforcement is variable, would suggest
disparate acquisition performance in the literature result from procedural differences.
Importantly, controlling for confounds associated with CB1 -/- mice, such as age and
motivation for food reward, must be considered in future studies.
Finally, there is a need for further research evaluating the cognitive impact of
enhancing eCB signaling through FAAH inhibition. The increased levels of brain
anandamide in FAAH -/- mice is correlated with accelerated acquisition rates in both
working (Varvel et al., 2006) and fixed-platform (Varvel et al., 2007) Morris water maze
tasks. As these reports represent the extent of the acquisition literature in FAAH -/- mice,
and utilize inherently aversive procedures, it is unknown whether limitations exist in the
expression of enhanced acquisition. Thus, performance in the aforementioned modified
Barnes maze provides an opportunity to determine if reinforcement conditions dictate the
expression of enhanced acquisition in FAAH -/- mice.

THE BARNES MAZE

Carol Barnes developed the first working model of the Barnes maze (fig. 1) in
1979 to study senescence in rats (Barnes, 1979). She hypothesized that the advantage of
this task is its superior control for different levels of stress between groups. For example,
many earlier tasks required a greater degree of food deprivation in older mice in an
attempt to generate ‘equal’ levels of motivation (Goodrick, 1968). Furthermore, motor
confounds related to age might be avoided by using an easily traversed land maze that did
not require more demanding motor performance such as with swimming. In her words
(personal communication):
“I developed this task in the mid-1970s for old rats - the idea was to come
up with a spatial memory task that didn't require shock, or food restriction
- in those days, you had to "grow your own" old rats, and I wanted them to
"want to participate" without risking health issues (if they died, there were
no replacements). This apparatus was the outcome - in its original
incarnation we put females (the rats in the study were males) in a cage
below the platform as extra incentive - but this turned out not to be
necessary for good performance. We also moved the platform to a huge
room, because I noticed that the rats became more 'comfortable' staying
out on the platform surface (even under bright lights) if the walls were
close to the edge.”
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The Barnes maze
utilizes natural sources of
motivation such as the
tendency to avoid bright
lights and air turbulence in
favor of an enclosed dark
Figure 1: The Barnes Maze (Barnes, 1979)

area, thereby avoiding

confounds relating to food deprivation, footshock,
stress, and stamina during studies of senescence
(Barnes, 1979). Years after its initial development for
rats, the maze was adapted for use in mice to evaluate
transgenic CaMKII -/- (Bach et al., 1995). In their
short description, the authors reported an increase in
the number, and reduction in the size, of the holes
along the perimeter of the maze, as well as the
inclusion of aversive stimuli (i.e. bright lights and a
buzzer). Fox et al., (1998) reported the first detailed
description of the adapted maze to evaluate traumatic
brain injury (fig. 2). However, little credit has been
given to both Fox et al., and Bach et al., for being the
first to adapt the Barnes maze for use in mice.

Figure 2: The Barnes maze for mice
(Fox et al., 1998)
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The current absence of an established
Barnes maze apparatus/procedure appears related
to the development of ‘pseudo-Barnes mazes,’
and begins with a report by Pompl et al., (1999).
In this study, the investigators utilized a
‘downsized circular platform’ (fig. 3) to evaluate
the cognitive performance of APPsw-/- mice.
Departing from the traditional, unenclosed open
field, the perimeter of the maze contained a
second set of cues. In their report, the authors extend Figure 1:The Barnes maze (Pompl et al.,
on the advantages (vs. the Morris water maze) listed

1999)

by Barnes (1979), adding that extensive pre-training is unnecessary, there is a minimal
reliance on sensorimotor skills, fewer required testing days than other spatial memory
tasks, and an inability for mice to use odor cues or exact motor sequences to solve the
task. Furthermore, they were the first to report the Barnes maze as less stressful than the
Morris water maze, an unsubstantiated claim that spread through the literature for years
thereafter. In their defense, there remains evidence that the stress induced by other
spatial memory models may affect results. For example, water temperature in the Morris
water maze can affect performance in a glucocorticoid dependent manner (Sandi et al.,
1997; Sandi, 1998). However, no work exists comparing these two spatial memory
paradigms directly (Harrison et al., 2006).
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While only a handful of reports have been published using the adapted Barnes
maze for mice, most have relied on similar sources of reinforcement. For example, many
reports utilize escape from aversive stimuli, such as bright lights (Bach et al., 1995; Fox
et al., 1998; Pompl et al., 1999; Inman-Wood et al., 2000; Williams et al., 2003; Bredy et
al., 2004), air turbulence (Pompl et al., 1999; Inman-Wood et al., 2000) rock and techno
music (Fabricius et al., 2008), and tones (Bach et al., 1995; Pompl et al., 1999; InmanWood et al., 2000; Bredy et al., 2004). Alternatively, some authors report the use of
appetitive (i.e. food reward) reinforcement (Grootendorst et al., 2001; Williams et al.,
2003). Moreover, some reports have suggested the return to the home cage, as well as
gentle handling (Harrison et al., 2006), are the primary source of reinforcement (Blizard
et al., 2003; Williams et al., 2003). Unlike other spatial memory tasks, the Barnes maze
is unique as it allows different sources of motivation (i.e. aversive vs. appetitive) to drive
the same behavior (e.g. entering the goal box) [for a summary of the literature, see
appendix A].
In the following dissertation, we capitalized on the unique nature of the Barnes
maze by comparing acquisition and extinction learning utilizing disparate sources of
reinforcement. Specifically, bright lights and air turbulence motivated learning under
aversive conditions (fig. 4 and 5), and access to water motivated learning under appetitive
conditions (fig. 6). Unlike previous publications, we chose to depart from sweetened
food reward under appetitive conditions in favor of water reward. As the present study
focuses on manipulations to the endocannabinoid system, water reward circumvented
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possible confounds related to appetite and hedonic value. Importantly, rimonabant has
been shown to leave water consumption unaffected (Arnone et al., 1997) at moderate
doses (Colombo et al., 1998). To our knowledge, this is the first report to use access to
water to motivate learning in the Barnes maze task.
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Figure 4: The Barnes maze (Harloe, 2007)

Figure 5: Unmodified goal box for aversive reinforcement conditions.

Figure 6: Goal box following modification for appetitive reinforcement conditions.

EXPERIMENT 1

INTRODUCTION

The environmental conditions necessary to observe disrupted extinction learning
following rimonabant administration are uncertain, but appear dependent on the source of
reinforcement. For example, rimonabant disrupts extinction in aversive conditioning
paradigms such as the Morris water maze, conditioned fear, and passive avoidance, but
not in appetitively reinforced operant conditioning procedures (Marsicano et al., 2002;
Holter et al., 2005; Varvel et al., 2005; Niyuhire et al., 2007). It is difficult to reconcile
between the qualitative hedonic value of the reinforcer (i.e., eliciting appetitivelymotivated versus aversively motivated behavior) and the disparate behavioral demands of
differing tasks. Thus, in order to discern whether the hedonic value of the reinforcer
plays a determining role in the outcome of dissimilar behavioral models, it is critical to
utilize a paradigm in which the nature of the reinforcement is varied but the behavioral
demands of the task remain constant. A unique aspect of the Barnes maze is that
different sources of reinforcement can be utilized to drive the same behavior (i.e., finding
and entering the goal box) to escape aversive stimuli or obtain appetitive reinforcement.
Here, we utilized bright lights and air turbulence to motivate learning under aversive
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conditions and access to drinking water under appetitive conditions. As future studies
will focus on the endocannabinoid system, water reward circumvented confounds related
to the observations that genetic disruption or pharmacological inhibition of the CB1
receptor often reduces operant responding for and the intake of palatable food (De Vry
and Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), though not always
(Jarrett et al., 2005). Importantly, compromising CB1 receptor signaling has been shown
to leave water consumption unaffected at moderate doses (Arnone et al., 1997; Colombo
et al., 1998). To the best of our knowledge, the studies presented in this dissertation are
the first to use access to drinking water to motivate learning in the Barnes maze task.
The initial objective of the present study was to characterize aversively- and
appetitively conditioned acquisition and extinction learning in the Barnes maze.
Moreover, these experiments allowed us to test the hypothesis that mice will exhibit
acquisition and extinction learning during both and appetitively and aversively motivated
Barnes maze task. In addition, a third group of subjects was assessed under conditions
common to both the aversive and appetitive procedures. In this control group, no bright
lights, air turbulence, water access, or water deprivation were used. Finally, a control
experiment was performed to differentiate between extinction learning and the gradual
decay of memory, or forgetting. In subsequent experiments, manipulations of the
endogenous cannabinoid system were evaluated in these appetitive and aversive tasks.

METHODS

SUBJECTS

A total of 79 C57BL/6J (Jackson Labs, Bar Harbor, ME) mice, weighing between
20-30 g, and housed individually, were used as subjects. All subjects were housed in a
temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad
libitum access to food. Mice in the ambient (n=8) or aversive condition (n=35) were
allowed ad libitum access to water in their home-cage for the entirety of the study, while
mice in the appetitive condition (n=36) were only given access to water for 2 h per day
(see procedure below). All experiments have been approved by the Institutional Animal
Care and Use Committee at Virginia Commonwealth University.
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APPARATUS

The Barnes maze (Hamilton-Kinder, Poway, CA) consisted of a round board (122
cm diameter) fabricated from PVC with 40 holes (2.54 cm diameter) surrounding the
perimeter of the maze. The maze was divided into six zones, each containing a possible
location for the goal box (19.5 cm X 5.5 cm). A square 152 cm X 152 cm aluminum
frame enclosure surrounded the apparatus and was used to hang contextual cues (i.e.
various dark shapes) on white curtains that encircled the maze. A circular starting tube
(7.62 cm. internal diameter) was placed in the center of the maze to ensure that all
subjects began each trial from the same location. The tube was attached to a cord and
pulley system, which the investigator could raise from outside the enclosure. The trial
began 3 s after the subject was placed in the starting tube. A digital camera (Panasonic
BP-330), connected to a nearby computer running AnyMaze software (Stoelting, Wood
Dale, IL), allowed the observer to watch and record without disturbing the subject. Both
the maze and goal box were wiped with an ammonia based cleaner (Whistle
[JohnsonDiversey Inc., Sturtevant, WI]) after each trial.
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PROCEDURE

Three types of testing conditions were used: aversive, ambient, and appetitive. In
the aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide
fans (Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and
remained on during all stages and trials. In the appetitive procedure, a modified goal box
containing access to water was used as a reinforcer for water-deprived mice. Subjects
were given 22 h of daily water deprivation before each session and were weighed for
comparison to a pre-deprivation baseline. Immediately after each session, the mice were
returned to their home cages, given access to water for 2 h, and weighed. Finally, in the
ambient condition, stimuli were limited to those inherent to the laboratory environment
(e.g. fluorescent lighting) and the Barnes maze apparatus (e.g. entering the goal box)
during appetitive and aversive procedures. No additional stimuli or water restriction
were introduced.

Shaping

All subjects were acclimated to the apparatus and basic procedure before formal
acquisition training began. The subject was placed in the start cylinder and was released
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once the experimenter had closed the curtain and initiated the software. Three min later,
the subject was placed in the goal box, which was then slid into one of the six
corresponding target locations. A metal lid was placed over the escape hole to prevent
the mouse from exiting. Following two min of acclimation to the goal box, the mouse
was placed into its home cage for a 30 s intertrial interval (ITI). After the ITI, the goal
box was placed back into its corresponding location and the subject was guided from the
center of the maze to the entrance of the goal box. Shaping was concluded after at least
two consecutive entries into the goal box without provocation from the investigator.

Acquisition

Each mouse was given four acquisition trials per day for ten days. Each trial
ended when either three min had elapsed or the subject entered the goal box, whichever
occurred first. In the event that the mouse failed to enter the goal box within the three
min trial, it was placed in the center of the maze and the experimenter led it to the goal
box where it remained for 30 s before being returned to its home cage for the 30 s ITI. If
the mouse repeatedly found the goal box, but failed to enter, it was given additional
shaping in which it was again placed in the center of the maze and led to the escape hole,
a process that was repeated until the mouse entered the goal box without provocation
from the experimenter. Acquisition measures included test duration (latency to enter the
hidden goal box), total time spent immobile, distance traveled, and adjusted speed.
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Extinction

In order to assess extinction, the goal box was removed and subjects were given a
single, three-min probe trial per day for a total of 10 days. Extinction was inferred to
have occurred when the percentage of time spent in the target zone was significantly
reduced compared to the first probe trial or to chance levels (18%). Additionally, as with
acquisition, total time immobile, adjusted speed and distance traveled were analyzed to
assess locomotor effects.
To differentiate between forgetting and extinction, the mice were given 10 days of
acquisition training in either aversive (n=15) or appetitive (n=17) conditions, as described
above, and were then divided into two separate groups. The first group received 10 days
of extinction training. The second group remained in the vivarium during the first nine
days of extinction. On the tenth day after acquisition, this group was given a 3 min probe
trial to assess whether they still recalled the location of the hidden escape hole.
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STATISTICAL ANALYSES

AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate most of
the dependent measures of interest. The maze was divided into six zones to determine
the duration of time spent in the target zone (the zone that contained the goal box). Other
dependent measures of interest included adjusted speed (distance traveled/(latency to
enter – time immobile)), distance traveled, time spent immobile, and latency to enter the
goal box (test duration).
Results from comparison studies were analyzed using two-way mixed design
ANOVAs (treatment by session). A significant effect of motivating condition was
further analyzed for each condition by a one-way repeated measures ANOVA. Dunnett’s
post-hoc analysis with comparison to day one values was used when appropriate.
Significant interactions were analyzed in the same manner, but also included comparison
of reinforcing condition within each acquisition or extinction session using the Tukey
post-hoc test. Finally, a student’s t-test was used to distinguish between forgetting and
extinction. The accepted level of significance for the tests was p<0.05.

RESULTS

Acquisition of aversive, appetitive, and ambient conditioning groups

Figure 7A-D illustrates each of the dependent measures for acquisition in the
aversive, appetitive, and ambient conditions. A significant effect of acquisition day was
found for all dependent measures including distance [fig. 7A; F(9,396)=25.0, p<0.0001],
latency to enter [fig. 7B; F(9,396)=52.0, p<0.0001], adjusted speed [fig. 7C,
F(9,396)=26.0, p<0.0001], and time immobile [fig. 7D; F(9,396)=7.7, p<0.0001].
While subjects learned the task in each condition, differences in acquisition rates,
as well as locomotor effects, were detected. Specifically, a significant effect of
conditioning procedure was found for latency to enter [F(2, 396)=15.0, p<0.0001],
distance traveled [F(2,396)=6.4, p<0.01], time immobile [F(2,396)=9.9, p<0.001], and
adjusted speed [F(2,396)=8.2, p<0.001]. In each situation, no differences were found
between the aversive and appetitive conditioning group, but both were significantly
different from the ambient condition.
Significant interactions between conditioning procedure and acquisition day were
found for adjusted speed [F(18,396)=2.1, p<0.01] and time immobile [F(18,396)=3.5,
p<0.0001]. While subjects in the aversive and appetitive condition reached asymptotic
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performance based on latency to enter the hidden goal box, subjects under the ambient
condition showed significantly longer latencies to enter the goal box than the other two
groups. Additionally, subjects in the ambient condition showed no change in the amount
of time spent immobile [F(9,63)=1.5, p=0.1] over the 10 acquisition days. When speed
was adjusted to account for time spent immobile, all groups showed a gradual increase in
running speed over acquisition days (appetitive [F(9,162)=14.0, p<0.0001]; aversive
[F(9,171)=22.7, p<0.0001]; ambient [F(9,63)=3.8, p<0.001]).
Finally, water restricted subjects were weighed twice daily to investigate whether
they would be able to maintain a proper range of body weight following waterdeprivation. While subjects showed an initial drop in body weight, they quickly adjusted
to the schedule, never falling below 75% of their baseline weight (fig. 8). No apparent
differences in water consumption were observed, however considerable leakage from the
water bottle prevented accurate measurement.
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Figure 7: Mice learn to enter a hidden goal box in the Barnes maze under aversive,
appetitive, and ambient conditioning procedures. Panel A. Distance traveled to enter
the box (cm). Panel B. latency to enter the goal box. Panel C. Adjusted running speed
(cm/s) was determined by the following formula: [distance/(latency to enter – time
immobile)]. Panel D. average time spent immobile. The data for each session
represent the average of four daily trials ± SEM. # p<0.05 ## p<0.01 # vs. the
appetitive condition. $ p<0.05 $$ p<0.01 vs. aversive condition.  p<0.05 
p<0.01  vs. ambient reinforcement. N=8-20 mice/group. The data for each session
represent the average of four daily trials ± SEM. N=8-20 mice/group.
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Figure 8: Mice rapidly adapt to water deprivation. Average daily weight (g) recorded
before and after 2-h access to water following 22-h of deprivation. --------- indicates
average baseline weight prior to testing and the shaded error represents the standard
error of baseline weight. All data are represented as mean ± SEM. N=10.
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Extinction of aversive, appetitive, and ambient conditioning groups

Significant reductions in the percentage of time spent in the target zone across the ten
probe trials in the aversive conditioning procedure [fig. 9A; F(9,63)=6.4, p<0.05], the
appetitive conditioning procedure [fig. 9C; F(9,36)=3.5, p<0.01], and under ambient
conditions [fig. 9E; F(9,63)=4.4, p<0.001]. Additionally, the mice displayed a significant
decrease in adjusted speed across extinction trials in the aversive [fig. 9B; F(9,63)=9.3,
p<0.0001] and ambient [fig. 9D; F(9,63)=2.1, p<0.05], but not appetitive (fig. 9F;
p=0.51) condition. These results indicate that a 3 min daily extinction trial is sufficient
to produce extinction learning.
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Figure 9: Exposure to the Barnes maze after removal of the goal box leads to
extinction. Mice were given ten day of acquisition training in aversive (top panels),
appetitive (middle panels), or ambient (bottom panels) conditioning procedures. The
percentages of time spent in the target zone (i.e., the area formerly associated with the
goal box) are shown for each condition (panels A, C, and E). The dotted line from the
18% point of the ordinate spanning to the width of the abscissa indicates chance
performance. Adjusted speeds [distance/(latency to enter – total time immobile)] are
represented for aversive (panel B), appetitive (panel D), and ambient (panel F)
conditions. * p<0.05 ** p<0.01 vs. extinction day 1 values. ------- Represents chance
performance. All data are represented as mean ± SEM. N=5-8 mice/group.

53
Forgetting vs. extinction

In order to distinguish between extinction learning and forgetting, naive mice
were given 10 days of acquisition training in either the aversive conditioning procedure
or the appetitive conditioning procedure. The mice in each conditioning procedure were
divided into two groups, with the first group receiving a daily extinction trial for 10 days
(Group Extinction) and the second group (Group No Extinction) receiving only a single
probe trial that coincided with extinction day 10 for Group Extinction. As can be seen in
fig. 10A, Group Extinction in the aversive conditioning procedure displayed a significant
decrease in the percentage of time spent in the target zone across the ten probe trials,
[F(9,54)=2.8, p<0.01]. In contrast, Group No Extinction, which was given a single probe
trial ten days after acquisition, spent significantly more time in the target zone than
Group Extinction [t(13)=3.0, p<0.01]. Moreover, no differences were observed when
comparing the percentage of time spent in the target zone between the single probe trial
of Group No Extinction and the first extinction trial of Group Extinction [t(13)=.1,
p=0.93]).
A similar pattern of results was found when appetitive conditions were employed.
Again, Group Extinction showed a significant decrease in the percentage of time spent in
the target zone across the ten probe trials [fig. 10B, F(9,81)=4.1, p<0.001]. Group No
Extinction appeared to remember the location of the target box ten days after acquisition,
as they spent a similar amount in the target zone as Group Extinction on their first

54
extinction trial [t(15)=1.1, p=0.26]. Additionally, Group No extinction spent a
significantly greater percentage of time in the target area compared to Group Extinction’s
tenth trial [t(15)=4.9, p<0.001]. Thus, under both aversive and appetitive conditions,
subjects still recall the location of the escape box ten days after training. However, daily
three min exposures to the Barnes maze with no goal box present were sufficient to elicit
extinction under both conditioning regimens.

55

Figure 10: Extinction learning is independent of forgetting. Percentage of time
spent in the target zone (i.e., the zone previously containing the escape box) during
extinction of an aversively (panel A) and appetitively (panel B) conditioned Barnes
maze tasks. All subjects were given ten days of acquisition training, as described in
the methods. Following acquisition, subjects in Group Extinction were given ten
daily three min exposures to Barnes maze, but the goal box was removed. Group
No Extinction received a single three min trial in the Barnes maze without the goal
box that coinciding with extinction day 10 for Group Extinction. The dotted line
from the 18% point of the ordinate spanning to the width of the abscissa indicates
chance performance. *p< 0.05; **p<0.01 vs. Group Extinction. All data are
represented as mean ± SEM. N=7-10 mice/group.

DISCUSSION

While our lab has previously employed the Morris water maze to evaluate the role
of the endogenous cannabinoid system on extinction, this task is inherently aversive
(Morris, 1984). This notion is supported by the observation that water maze training
activates the pituitary adrenal axis, causing an increase in corticosterone (Sandi et al.,
1997; Akirav et al., 2001). Rimonabant disrupted extinction learning in the Morris water
maze (Varvel et al., 2005), as well as other aversively conditioned paradigms such as
passive avoidance and conditioned fear (Marsicano et al., 2002; Niyuhire et al., 2007).
Conversely, rimonabant does not affect extinction learning in appetitively conditioned
operant tasks (Holter et al., 2005; Niyuhire et al., 2007). In contrast, the Barnes maze
spatial memory paradigm presented a unique opportunity of comparing different sources
of reinforcement, either aversive or appetitive (i.e. food and entering the goal box), to
motivate the same goal. Only a handful of published reports have employed the Barnes
maze to evaluate mice and most of this work has relied on similar sources of aversive
reinforcement, such as bright lights, air turbulence, or auditory stimuli (Bach et al., 1995;
Fox et al., 1998; Pompl et al., 1999; Inman-Wood et al., 2000; Williams et al., 2003;
Bredy et al., 2004). Conversely, other studies have utilized positive reinforcement, such
as food, gentle handling, or the return to the home cage to motivate Barnes maze learning
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(Grootendorst et al., 2001; Blizard et al., 2003; Koopmans et al., 2003; Williams et al.,
2003; Harrison et al., 2006).
To focus on the qualitative nature of the reinforcer, we modified the Barnes maze
task in the present study to evaluate appetitively and aversively motivated conditioning
procedures on acquisition and extinction, but required the same motor responses (i.e.,
searching and entering the goal box). Subjects acquired the Barnes maze task
irrespective of reinforcement condition, illustrated by significant reductions in both path
length and test duration across acquisition days. Removal of the goal box following
acquisition trials produced a gradual decrease in the percentage of time spent in the target
zone for all conditions, indicating the occurrence of extinction learning. Importantly,
control experiments demonstrated extinction learning was independent of forgetting,
under both appetitive and aversive conditions. Collectively, the results support the
utilization of this model as a viable method of assessing spatial memory in a paradigm in
which the nature of reinforcement is variable, but the behavioral demands of the task
remain constant.
The Barnes maze is traditionally used to assess spatial memory, requiring the
subject to use spatial cues to find a hidden location (Bach et al., 1995). It has been
reported that animals progress through random, serial, and direct search strategies during
acquisition of the Barnes maze task (Barnes, 1979). While we initially attempted to
record these three search strategies, we elected not to use this measure. There is
difficulty in objectively scoring these strategies because subjects often, in no particular
order, utilize all three strategies within a single acquisition day, though by the completion
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of acquisition training, nearly every subject adopted the direct strategy. Accordingly, we
elected to rely on path length and latency to enter the hidden goal box measures to infer
learning and percentage of time spent in the target zone to infer extinction learning.
Results garnered from the ambient condition indicate that mice placed on the
Barnes maze, without any extra environmental manipulations (e.g., bright lights, air
turbulence, or access to water) will learn to enter the hidden box, though they do not enter
the goal box as quickly as mice in the aversive or appetitive conditioning procedures,
suggesting environmental manipulations increased acquisition rates. Additionally, when
the hidden goal box was removed, the mice in the ambient condition extinguished
searching in the target zone at a similar rate as the mice in the other two groups. Thus,
mere placement onto the Barnes maze is a sufficient motivator for mice to learn to find
and enter the goal box. The finding that the mice prefer the goal box to remaining on the
open maze is not surprising given that open fields generally provoke anxiety-like states in
rodents (Crawley, 1985).

EXPERIMENT 2

INTRODUCTION
A growing body of literature has implicated the eCB system in extinction learning
in which learned behavior becomes suppressed when reinforcement is withheld.
Disruption of CB1 receptor signaling, through either its genetic deletion or administration
of a receptor antagonist impairs extinction learning in a variety of aversively motivated
tasks, including conditioned freezing (Marsicano et al., 2002; Suzuki et al., 2004;
Kamprath et al., 2006; Niyuhire et al., 2007), passive avoidance (Niyuhire et al., 2007),
and the Morris water maze spatial memory task (Varvel et al., 2005). A common aspect
of these tasks is that each uses an aversive unconditioned stimulus. In contrast,
disruption of CB1 receptor signaling failed to affect extinction learning in operant
conditioning tasks that use palatable food as the reinforcer (Holter et al., 2005; Niyuhire
et al., 2007; Ward et al., 2007). Specifically, CB1 -/- mice displayed similar rates of
extinction as wild type mice in nose-poking tasks for food pellets (Holter et al., 2005) as
well as for EnsureR (a sweetened protein drink) or corn oil (Ward et al., 2007). To
account for the differential consequences of CB1 deletion on extinction learning in
operant and other behavioral paradigms, Holter et al (2005) hypothesized that the eCB
system plays an important role in extinction of aversively-motivated learned behavior,
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but is dispensable for the extinction of appetitively-motivated behavior. Similarly,
rimonabant treatment failed to affect extinction rates in a lever pressing operant task for
sweetened condensed milk (Niyuhire et al., 2007), providing pharmacological evidence
the CB1 receptor does not play a role in extinction of appetitively-motivated behavior.
It is difficult to reconcile between the qualitative hedonic value of the reinforcer
(i.e., eliciting appetitively-motivated versus aversively motivated behavior) and the
disparate behavioral demands of differing tasks. Thus, in order to discern whether the
hedonic value of the reinforcer plays a determining role in the activation of the
endogenous cannabinoid system, it is critical to utilize a behavioral paradigm in which
the nature of the reinforcement is varied but the behavioral demands of the task remain
constant. In the present study, we used modified versions of the Barnes maze (Barnes,
1979), characterized and evaluated in the previous chapter, to examine the consequences
of pharmacologically blocking endocannabinoid signaling on extinction learning in mice.
A unique aspect of the Barnes maze is that different sources of reinforcement can be
utilized to drive the same behavior (i.e., finding and entering the goal box) to escape
aversive stimuli or obtain appetitive reinforcement. Here, we utilized bright lights and air
turbulence to motivate learning under aversive conditions and access to drinking water
under appetitive conditions. As the present study focuses on manipulations to the
endocannabinoid system, water reward circumvented confounds related to the
observations that genetic disruption or pharmacological inhibition of the CB1 receptor
often reduces operant responding for and the intake of palatable food (De Vry and
Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), though not always (Jarrett
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et al., 2005). Importantly, compromising CB1 receptor signaling has been shown to leave
water consumption unaffected at moderate doses (Arnone et al., 1997; Colombo et al.,
1998).
The primary objective of this study was to test the hypothesis that the endogenous
cannabinoid system plays a differential role in modulating extinction in aversive and
appetitive conditioning paradigms. While the behavioral demands (i.e., locating and
entering the escape box) for conditioning was kept constant, the qualitative value of the
reinforcement was experimentally manipulated. In the present study, we evaluated the
effects of rimonabant administration in appetitive and aversive Barnes maze tasks.
Accordingly, we sought to determine the outstanding question of whether observed
differences of rimonabant on extinction learning were due to hedonics or the disparate
nature of the tasks utilized.

METHODS
SUBJECTS

A total of 71 C57BL/6J (Jackson Labs, Bar Harbor, ME) mice, weighing between
20-30 g, and housed individually, were used as subjects. All subjects were housed in a
temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad
libitum access to food. Mice in the aversive condition (n=53) were allowed ad libitum
access to water in their home-cage for the entirety of the study, while mice in the
appetitive condition (n=18) were only given access to water for 2 h per day (see
procedure below). All experiments have been approved by the Institutional Animal Care
and Use Committee at Virginia Commonwealth University.
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DRUGS

Rimonabant (SR-141716A) was obtained from the National Institute on Drug
Abuse (Rockville, MD). The drug was dissolved into a vehicle consisting of ethanol,
alkamuls-620 (Rhone-Poulenc, Princeton, NJ), and saline at a ratio of 1:1:18, and a 3
mg/kg dose was administered i.p. 30 min prior to testing at a volume of 10 ml/kg.
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APPARATUS

The Barnes maze (Hamilton-Kinder, Poway, CA) consisted of a round board (122
cm diameter) fabricated from PVC with 40 holes (2.54 cm diameter) surrounding the
perimeter of the maze. The maze was divided into six zones, each containing a possible
location for the goal box (19.5 cm X 5.5 cm). A square 152 cm X 152 cm aluminum
frame enclosure surrounded the apparatus and was used to hang contextual cues (i.e.
various dark shapes) on white curtains that encircled the maze. A circular starting tube
(7.62 cm. internal diameter) was placed in the center of the maze to ensure that all
subjects began each trial from the same location. The tube was attached to a cord and
pulley system, which the investigator could raise from outside the enclosure. The trial
began 3 s after the subject was placed in the starting tube. A digital camera (Panasonic
BP-330), connected to a nearby computer running AnyMaze software (Stoelting, Wood
Dale, IL), allowed the observer to watch and record without disturbing the subject. Both
the maze and goal box were wiped with an ammonia based cleaner (Whistle
[JohnsonDiversey Inc., Sturtevant, WI]) after each trial.
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PROCEDURE

Two types of testing conditions were used: aversive and appetitive. In the
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and
remained on during all stages and trials. In the appetitive procedure, a modified goal box
containing access to water was used as a reinforcer for water-deprived mice. Subjects
were given 22 h of daily water deprivation before each session and were weighed for
comparison to a pre-deprivation baseline. Immediately after each session, the mice were
returned to their home cages, given access to water for 2 h, and weighed.

Shaping

All subjects were acclimated to the apparatus and basic procedure before formal
acquisition training began. The subject was placed in the start cylinder and was released
once the experimenter had closed the curtain and initiated the software. Three min later,
the subject was placed in the goal box, which was then slid into one of the six
corresponding target locations. A metal lid was placed over the escape hole to prevent
the mouse from exiting. Following two min of acclimation to the goal box, the mouse
was placed into its home cage for a 30 s intertrial interval (ITI). After the ITI, the goal
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box was placed back into its corresponding location and the subject was guided from the
center of the maze to the entrance of the goal box. Shaping was concluded after at least
two consecutive entries into the goal box without provocation from the investigator.

Acquisition

Each mouse was given four acquisition trials per day for ten days. Each trial
ended when either three min had elapsed or the subject entered the goal box, whichever
occurred first. In the event that the mouse failed to enter the goal box within the three
min trial, it was placed in the center of the maze and the experimenter led it to the goal
box where it remained for 30 s before being returned to its home cage for the 30 s ITI. If
the mouse repeatedly found the goal box, but failed to enter, it was given additional
shaping in which it was again placed in the center of the maze and led to the escape hole,
a process that was repeated until the mouse entered the goal box without provocation
from the experimenter. Acquisition measures included test duration (latency to enter the
hidden goal box), total time spent immobile, distance traveled, and adjusted speed.

Extinction

In order to assess extinction, the goal box was removed and subjects were given a
single, three-min probe trial per day for a total of 10 days. Extinction was inferred to
have occurred when the percentage of time spent in the target zone was significantly
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reduced compared to the first probe trial or to chance levels (18%). The latency to find
the target hole, time spent immobile, and the number of nose pokes into the target hole
were assessed during extinction. Additionally, as with acquisition, adjusted speed and
distance traveled were analyzed to assess locomotor effects.
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STATISTICAL ANALYSES

AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate most of
the dependent measures of interest. The maze was divided into six zones to determine
the duration of time spent in the target zone (the zone that contained the goal box). Other
dependent measures of interest included adjusted speed (distance traveled/(latency to
enter – time immobile)), distance traveled, time spent immobile, and latency to enter the
goal box (test duration).
Results from comparison studies were analyzed using two-way mixed design
ANOVAs (treatment by session). A significant effect of treatment was further analyzed
for each drug condition by a one-way repeated measures ANOVA. Dunnett’s post-hoc
analysis with comparison to day one values was used when appropriate. Significant
interactions were analyzed in the same manner, but also included comparison of
treatment within each acquisition or extinction session using the Tukey post-hoc test.
The accepted level of significance for the tests was p<0.05.

RESULTS

Rimonabant fails to affect Barnes maze acquisition

Rimonabant (3 mg/kg) failed to alter path lengths under both aversive (fig. 11A;
p=0.14) and appetitive (fig. 12A; p =0.75) conditioning tasks, though the drug-treated
mice had significantly longer path lengths than vehicle-treated mice on day 4, only.
Similarly, rimonabant failed to affect the latency to enter the goal box during acquisition
in aversive (fig. 11B; p=0.09) and appetitive (fig. 12B; p=0.18) conditioning Barnes
maze procedures. Rimonabant failed to affect speed during acquisition in the aversive
(fig. 11C; p=0.68) and appetitive (fig. 12C; p=0.13) conditioning tasks. During the first
few conditioning sessions, the rimonabant-treated mice displayed more immobility than
vehicle-treated mice, as indicated by significant interactions between drug treatment and
conditioning day in aversive [fig. 11D; F(9,315)=2.3, p<0.05] and appetitive [fig. 12D;
F(9,144)=2.0, p<0.05] procedures.
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Figure 11: Rimonabant administration (3 mg/kg) increases immobility time, but does
not affect acquisition of an aversively conditioned Barnes maze task. The average
distance (cm) traveled (panel A), and the corresponding latency (s) to enter the goal box
(panel B), did not significantly differ between groups. Panel C. No treatment
differences were observed for adjusted speed [distance/(latency to enter – total time
immobile)]. Panel D. Rimonabant increased time spent immobile during the first few
conditional trials. $ p<0.05 $$ p<0.01 vs. the corresponding vehicle-treated mice. The
data for each acquisition session are represented as the average of four daily trials ±
SEM. $ denotes a significant difference from vehicle treatment. N=17-20 mice/group.
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Figure 12: Rimonabant administration (3 mg/kg) increases immobility time, but does
not affect acquisition, in an appetitively conditioned Barnes maze task. The average
distance (cm) traveled (panel A), and the corresponding latency (s) to enter the goal
box (panel B), did not significantly differ between groups. Panel C. No differences
were observed for adjusted speed [distance/(latency to enter – total time immobile)].
Panel D. A significant increase in time spent immobile was observed following
rimonabant treatment. $ p<0.05 vs. vehicle group. The data for each acquisition
session are represented as the average of four daily trials ± SEM. N=9 mice/group.
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Rimonbant disrupts extinction learning in an aversive, but not in an appetitive, Barnes
maze task

In an initial experiment, subjects were administered rimonabant or vehicle during
both acquisition and extinction. The percentage of time spent in the target zone in both
groups across extinction trials is shown in fig. 13A, and track plots of a representative
mouse for each treatment group on Day 1 and Day 10 of extinction are shown in fig. 15
(top traces). A significant drug by day interaction [F(9,306)=2.0, p<0.05] was found,
indicating that the rimonabant-treated mice displayed a significant delay in extinction
rate. Whereas the vehicle control group underwent extinction following repeated trials
without the goal box present [F(9,171)=9.1, p<0.0001], the rimonabant-treated group
failed to display any evidence of extinction (p=0.76). Specifically, the vehicle-treated
mice spent significantly less time in the target zone by extinction day 2, while
rimonabant-treated animals continued to perseverate in the target zone throughout all 10
extinction trials. Rimonabant treatment did not affect speed (fig. 13B; p=0.79), or
distance traveled (p=0.60; data not shown), but did significantly increase the amount of
time spent immobile [fig. 13C; F(1,306)=4.4, p<0.05].
In the next experiment, rimonabant was administered before each extinction
session, but not during acquisition. Again, administration of rimonabant led to extinction
deficits, as indicated by the percentage of time spent in the target zone [fig. 13D;

74
F(9,126)=2.2, p<0.05]. The vehicle-treated mice showed a reduction in the percentage of
time spent in the target area [F(9,63)=8.2, p<0.0001], with a significant decrease in the
target zone by day 3. On the other hand, rimonabant-treated mice continued to
perseverate in the target zone across all ten extinction sessions, with no reductions
(p=0.45). As in the previous experiment, rimonabant failed to affect adjusted speed (fig.
13E; p=0.58); however, rimonabant treatment failed to produce a significant effect on
immobility time [fig. 13F; F(1,126)=3.6, p=0.07].
In the appetitive Barnes maze conditioning paradigm, rimonabant failed to alter
extinction learning. Both rimonabant- and vehicle-treated subjects exhibited a gradual
reduction in the percentage of time spent in the target zone [fig. 14A; F(9,126)=6.1,
p<0.0001]. However, neither a main effect of drug (p=0.68) nor an interaction between
drug and extinction day (p=0.99) was observed. Finally, there were no significant effects
of treatment condition on adjusted speed (fig. 14B; p=0.57), distance traveled (p=0.59;
data not shown), or time spent immobile (fig. 14C; p=0.79). Representative traces of
vehicle-treated and rimonabant-treated mice on Days 1 and 10 of extinction are shown in
Figure 15 (bottom panel).
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Figure 13: Rimonabant impairs extinction learning in the aversively motivated Barnes
maze task. In the first experiment (left panels), subjects were administered vehicle or
rimonabant(3 mg/kg) before each acquisition and extinction trial, whereas rimonabant
was only administered before each extinction session in the second experiment (right
panels). In both experiments, rimonabant, but not vehicle, treatment produced a
perseverant effect in the target zone across ten daily, 3-min extinction trials, based on
the percentages of time spent in the zone that previously contained the escape box
(panels A and D). The dotted line from the 16.7% point of the ordinate spanning to
the width of the abscissa indicates chance performance. Panels B and E. No treatment
effect was observed for either experiment on adjusted speed [distance/(180 – total time
immobile)]. Rimonabant treatment significantly increased time spent immobile (s) in
experiment 1 (panel C), but not in experiment 2 (panel F, p=0.07). * p< 0.05; **
p<0.01 vs. extinction day 1 for each respective group. $ p<0.05 vs. the vehicle group.
All data are represented as mean ± SEM. N=8-20 mice/group.
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Figure 14: Rimonabant fails to affect extinction learning in an appetitively
conditioned Barnes maze task. Panel A. Both rimonabant and vehicle treatment
groups exhibited a significant decrease in the percentage of time spent in the target
zone, which previously contained the goal. The dotted line from the 16.7% point of
the ordinate spanning to the width of the abscissa indicates chance performance.
Adjusted running speeds [distance/(180 – total time immobile); panel B], as well as
total time spent immobile (panel C) were unaffected by treatment condition. All data
are represented as mean ± SEM. N=7-9 mice/group.
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Figure 15: Track plots of representative vehicle- and rimonabant-treated mice in
aversive (top panels) and appetitive (bottom panels) conditioning procedures on Days
1 and 10, from the experiments presented in figures 13 and 14. The target zone (i.e.,
the area that previously contained the goal box) for each trace is highlighted.
Additionally, the plots have been rotated to display the target zone at the bottom.

DISCUSSION

Rimonabant treatment disrupted extinction learning under aversive, but not under
appetitive conditions. These data strongly support the hypothesis that the
endocannabinoid system mediates learning under aversive conditions, but is dispensable
for appetitively-motivated learning (Holter et al., 2005). Unlike previous reports, this
study represents the first case investigating the neurochemical mechanisms underlying
extinction learning in which the same behavioral demands were required (i.e. locating
and entering the goal box) and only the reinforcement was varied. Control mice trained
in either the aversive or appetitive Barnes maze conditioning paradigm showed a gradual
decline in the percentage of time spent in the target zone across the extinction trials. The
rimonabant-treated mice trained in the aversive conditioning procedure continued to
spend significantly more time in the zone that previously contained the escape box than
each of the other zones throughout extinction training. In contrast, the vehicle-treated
mice showed a gradual decline in the percentage of time spent in the target zone across
the extinction trials. Conversely, in the appetitive task, rimonabant-treated mice showed
a virtually identical decrease in the percentage of time spent in target zone as vehicletreated mice. Importantly, previous control experiments demonstrated extinction learning
was independent of forgetting, under both appetitive and aversive conditions.
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These data support the initial hypothesis of Holter et al., (2005) that the
endocannabinoid system is dispensable for extinction learning in an appetitivelymotivated learning tasks. Specifically, they found CB1 -/- and +/+ mice displayed similar
extinction rates in an operant nose-poke for food paradigm. Similarly, Niyuhire et al,
(2007) reported that rimonabant administration (1 or 3 mg/kg) failed to alter extinction
rates in an appetitively-motivated operant conditioning paradigm in which the mice were
trained to press a lever for access to sweetened milk, though rimonabant administration
produced a reduction in the extinction burst on the first extinction trial. Finally, Ward et
al (2007) found no differences in extinction learning between CB1 -/- and +/+ mice.
There are three alternative explanations for the apparent lack of evidence
supporting endocannabinoid modulation of appetitively motivated extinction. First,
disruption of CB1 receptor signaling has been demonstrated to decrease salience of food
reward (Ward and Dykstra, 2005), decreased salience for palatable sucrose solution
(Higgs et al., 2003), and reduce operant responding for food (De Vry and Jentzsch, 2004;
Holter et al., 2005; Ward et al., 2007). It is important to note that Holter et al., (2005)
employed a more stringent deprivation schedule in the CB1 -/- mice than the wild type
counterparts in order to ensure that both genotypes displayed similar response rates.
Similarly, Ward et al., (2007) analyzed extinction as a percentage of baseline responding
during maintenance sessions. Nonetheless, in both experiments the CB1 -/- mice still
displayed equivalent extinction rates as the wild type mice. Second, recent evidence has
emerged showing that CB1 -/- mice exhibit an accelerated and age-related deficit in
cognitive ability, which was associated with the loss of hippocampal neurons beginning
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at three months of age (Bilkei-Gorzo et al., 2005). Importantly, Holter et al.,(2005)
utilized CB1 -/- mice that were 11-14 weeks and Ward et al., (2007) used 7-8 month-old
mice (Ward, October 2007, Personal Communication), corresponding with significant
cognitive deficits found by Bilkei-Gorzo et al.(2005) in other learning paradigms. Thus,
the age-related neurodegeneration in the CB1 -/- mice may play a contributing role in the
reported extinction deficits, though this explanation would not hold for rimonabanttreated animals.
A third challenge in interpreting the role of the endogenous cannabinoid system
on extinction learning is the difficulty in comparing the results of experiments across
different behavioral paradigms. Each of the reports examining appetitively motivated
conditioning tasks employed an operant procedure, which has qualitatively different
behavioral demands than learning paradigms employing either electric shock as the
unconditioned stimulus (i.e., conditioned freezing and passive avoidance) or the Morris
water maze. Thus, it may be that extinction of operant behavior, rather than the hedonic
value of the reinforcer, is refractory to CB1 receptor disruption. Moreover, the reinforcers
in the conditioned freezing, passive avoidance, Morris water maze, and operant tasks are
qualitatively different and not interchangeable. To focus on the qualitative nature of the
reinforcer, we modified the Barnes maze task in the present study to evaluate appetitively
and aversively motivated conditioning procedures on extinction, but required the same
motor responses (i.e., searching and entering the goal box). Additionally, we departed
from employing highly palatable food rewards in favor of water to limit confounding
variables related to motivational factors. Notably, rimonabant administration does not
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affect water consumption (Arnone et al., 1997), an observation supported by the present
study. The differential effects of rimonabant on extinction in our two Barnes maze tasks
support the hypothesis that the endocannabinoid system is dispensable for the extinction
of appetitively motivated behaviors.
While we have previously employed the Morris water maze to evaluate the role of
the endogenous cannabinoid system on extinction, this task is inherently aversive
(Morris, 1984) . This notion is supported by the observation that water maze training
activates the pituitary adrenal axis, causing an increase in corticosterone (Sandi et al.,
1997; Akirav et al., 2001). In contrast, the Barnes maze spatial memory paradigm
presented a unique opportunity of comparing different sources of reinforcement, either
aversive or appetitive (i.e. food and entering the goal box), to motivate the same goal.
Only a handful of published reports have employed the Barnes maze to evaluate mice and
most of this work has relied on similar sources of aversive reinforcement, such as bright
lights, air turbulence, or auditory stimuli (Bach et al, 1995; Fox et al, 1998; Williams et
al, 2003; Pompl et al, 1999; Inman-Wood et al, 2000; Bredy et al, 2004). Conversely,
other studies have utilized positive reinforcement, such as food, gentle handling, or the
return to the home cage to motivate Barnes maze learning (Grootendorst et al, 2001;
Williams et al, 2003; Blizard et al, 2003; Koopmans et al, 2003; Harrison et al, 2006). In
concert with results from the Morris water maze spatial memory paradigm, rimonabant
treatment disrupted extinction learning in the aversive conditioning task. Furthermore,
our results indicate that rimonabant administration during acquisition is not necessary to
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affect extinction in aversive conditions. In contrast, rimonabant failed to affect
extinction learning in the appetitive version of the task.
Rimonabant did not affect acquisition of either an appetitively- or an aversivelyconditioned Barnes maze task. These data are in agreement with previous results from
the Morris water maze (Varvel et al., 2005), passive avoidance (Mazzola et al., 2003;
Niyuhire et al., 2007), conditioned fear (Marsicano et al., 2002; Suzuki et al., 2004;
Kamprath et al., 2006; Niyuhire et al., 2007), and operant conditioning paradigms
(Mallet and Beninger, 1998; Niyuhire et al., 2007). Of interest, rimonabant treatment
significantly increased immobility time under both aversive and appetitive conditions of
reinforcement. One possible explanation for the increased immobility time is an
anxiogenesis, and is supported by the observation that rimonabant dose-dependently
increases plasma corticosterone (Patel et al., 2004; Wade et al., 2006; Steiner et al.,
2008). However, indistinguishable performance during the first extinction trial would
suggest that both vehicle and rimonabant treated subjects acquired the task to a
comparable degree.
Pharmacotherapies directed at the endocannabinoid system hold potential promise
for the treatment of a variety of maladies including, pain and inflammation (Lichtman et
al., 2004; Hohmann et al., 2005), obesity (Rinaldi-Carmona et al., 1994), drug abuse
(Arnone et al., 1997), diabetes (Anthenelli and Despres, 2004), anxiety (Gaetani et al.,
2003; Kathuria et al., 2003), depression (Gobbi et al., 2005; Hill and Gorzalka, 2005),
and possibly post traumatic stress syndrome (Marsicano et al., 2002; Chhatwal et al.,
2005; Varvel et al., 2007). The results presented here provide compelling evidence that
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the endocannabinoid system mediates the extinction of behaviors that are associated with
aversive memories, leaving extinction of learned behaviors from appetitively reinforced
tasks intact. While it is unknown whether the endocannabinoid system is involved in the
extinction of other forms of positively reinforced (e.g. mating) behavior, the system’s
impact on aversively motivated learning is clear. These results underscore the concern
over the therapeutic use of rimonabant or other cannabinoid receptor antagonists.
Specifically, contraindication might be warranted for patients diagnosed with
posttraumatic stress syndrome, as this disorder is believed to contain an element in which
patients display deficits in extinguishing certain maladaptive behaviors associated with
anxiety or panic attacks (Rothbaum and Davis, 2003). This observation is further
supported by a recent meta-analysis of rimonabants clinical trials, reporting a 40%
increase in side effects ranging from depression and anxiety to suicidal thoughts
(Christensen et al., 2007). Conversely, pharmacotherapies that enhance
endocannabinoid signaling, such as FAAH inhibitors or a cannabinoid receptor agonists,
may accelerate extinction of aversively motivated behaviors. In conclusion, the results of
the present study are the first to show a differential effect of rimonabant on extinguishing
a learned behavior that only differed in the hedonic nature of the reinforcer.

EXPERIMENT 3

INTRODUCTION

A growing body of research has employed genetically altered mice to examine the
role that the endocannabinoid system plays on learning. However, conflicting reports
exist regarding how acquisition is affected, and under what conditions. Genetic
disruption of CB1 receptor signaling enhances acquisition of an active avoidance
paradigm (Martin et al., 2002), but impairs contextual conditioned fear (Mikics et al.,
2006), and delay eyeblink conditioning (Kishimoto and Kano, 2006). On the other hand,
CB1 -/- mice display similar acquisition as wild-type mice in the Morris water maze
(Varvel and Lichtman, 2002; Varvel et al., 2005), cued conditioned fear (Marsicano et
al., 2002; Cannich et al., 2004; Kamprath et al., 2006), and trace eyeblink conditioning
(Kishimoto and Kano, 2006) tasks. Differences in procedural demands may underlie the
disparate nature of these reports.
Under conditions of appetitive reinforcement, a more uniform collection of results
have been reported. Bilkei-Gorzo et al., (2005), were the first to report intact acquisition
of an operant conditioning procedure in young (6-7 weeks of age) CB1 -/- mice compared
to age-matched controls. However, mature (3-5 months old) and old (14-17 months) CB1
-/- mice exhibited an accelerated age-dependent decline in acquisition of the task
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compared to controls, suggesting differences in age warrant consideration when
interpreting results from studies utilizing CB1 -/- mice . For example, acquisition
learning was unaffected in operant conditioning experiments utilizing mature CB1 -/- and
+/+ mice trained to nose-poke for food pellets (Holter et al., 2005), Ensure (a sweetened
protein drink), or corn-oil (Ward et al 2007; Ward, personal communication, 2007).
However, as CB1 -/- mice exhibit reduced motivation for food-reward, the extent to
which phenotypic differences in hedonics may have contributed to these results remains
unknown (Holter et al., 2005; Ward and Dykstra, 2005; Ward et al., 2007).
For this dissertation, I developed a novel Barnes maze procedure in which a
variable source of reinforcement (i.e., aversive or appetitive) is used to motivate the
acquisition of a consistent goal (i.e., finding and entering the goal box). Application of
this new procedure presented the opportunity to clarify the relative importance of
procedural demands and hedonics, with regards to the expression of genotypic
differences in acquisition learning. Age-matched CB1 -/- and +/+ litter-mate controls
were given acquisition training under conditions of aversive or appetitive reinforcement
conditions. In the appetitive procedure, the mice were water restricted and access to
water served as the appetitive reinforcer. Importantly, water consumption is unaffected
by genetic deletion of the CB1 receptor (Poncelet et al., 2003; Thanos et al., 2005). The
initial objective of this study was to provide a complementary approach to previous
studies utilizing rimonabant during extinction. However, the data presented here
revealed an impaired acquisition phenotype in CB1 -/- mice, confounding the
interpretation of extinction results. Thus, the purpose of this study was to compare the
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consequence of CB1 receptor deletion in acquisition of appetitive and aversive Barnes
maze conditioning procedures. To this end, we tested the hypothesis that acquisition
deficits associated with CB1 receptor deletion are dependent hedonics, and CB1 -/- mice
would exhibit impaired acquisition and extinction learning under aversive, but not
appetitive, reinforcement conditions.

METHODS

SUBJECTS

Subjects included CB1 -/- (n=17) and CB1 +/+ (n=17) mice between 8-16 weeks
of age, on the C57BL/6 background that were born from breeding pairs at Virginia
Commonwealth University. The original breeding pairs were obtained from Zimmer et
al., (1999). All subjects were housed in a temperature-controlled (20-22º C)
environment, with a 12-h light/dark cycle and ad libitum access to food. In the appetitive
condition, the same methodology as previously described was utilized. In short, subjects
were deprived of access to water for 22 h per day. Upon completion of each acquisition
session, subjects were allowed access to water for 2 h per day. All experiments were
approved by the Institutional Animal Care and Use Committee at Virginia
Commonwealth University.
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PROCEDURE

Two types of testing conditions were used: aversive and appetitive. In the
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and
remained on during all stages and trials. In the appetitive procedure, a modified goal box
containing access to water was used as a reinforcer for water-deprived mice. Subjects
were given 22 h of daily water deprivation before each session and were weighed for
comparison to a pre-deprivation baseline. Immediately after each session, the mice were
returned to their home cages, given access to water for 2 h, and weighed.

Shaping
Shaping occurred as described previously. In summary, all subjects were
acclimated to the apparatus and basic procedure before formal acquisition training began.
The subject was placed in the start cylinder and released. Three min later, the subject
was placed in the goal box, which was then slid into one of the six corresponding target
locations. Following two min of acclimation to the goal box, the mouse was placed into
its home cage for a 30 s intertrial interval (ITI). After the ITI, the goal box was placed
back into its corresponding location and the subject was guided from the center of the
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maze to the entrance of the goal box. Shaping was concluded after at least two
consecutive entries into the goal box without provocation from the investigator.
Acquisition
Again, the same acquisition procedure as previously described was employed.
Each mouse was given four acquisition trials per day for ten days. Each trial ended when
either three min had elapsed or the subject entered the goal box, whichever occurred first.
In the event that the mouse failed to enter the goal box within the three min trial, it was
placed in the center of the maze and the experimenter led it to the goal box where it
remained for 30 s before being returned to its home cage for the 30 s ITI. If the mouse
repeatedly found the goal box, but failed to enter, it was given additional shaping in
which it was again placed in the center of the maze and led to the escape hole, a process
that was repeated until the mouse entered the goal box without provocation from the
experimenter. Acquisition measures included test duration (latency to enter the hidden
goal box), total time spent immobile, distance traveled, and adjusted speed
[distance/(latency to enter – time immobile)].
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STASTICAL ANALYSES

AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate the
dependent measures of interest. As reported, measures of interest included adjusted
speed (distance traveled/(latency to enter – time immobile)), distance traveled, time spent
immobile, and latency to enter the goal box (test duration).
Results from comparison studies were analyzed using two-way mixed design
ANOVAs (genotype by session). A significant effect of genotype was further analyzed
for each genotype condition by a one-way repeated measures ANOVA. Dunnett’s posthoc analysis with comparison to day one values was used when appropriate. Significant
interactions were analyzed in the same manner, but also included comparison of genotype
within each acquisition session using the Tukey post-hoc test.

RESULTS

CB1 -/- mice exhibit deficits in acquiring an aversively conditioned Barnes maze task
Under the aversive conditioning procedure, both CB1 -/- and +/+ mice acquired
the task in a manner consistent with previous experiments, exhibiting a gradual reduction
in distance traveled [fig. 16A; F(9,144)=20.6, p<0.0001], latency to enter [fig. 16B;
F(9,144)=30.9, p<0.0001], and time immobile [fig. 16C; F(9,144)=4.7, p<0.0001].
Genetic ablation of the CB1 receptor disrupted acquisition learning, exhibited by a
significant genotype effect of distance [F(1,144)=18.5. p<0.001], as well as the
corresponding latency to enter [F(1,144)=26.4, p<0.0001]. While no genotype
differences were observed for adjusted speed [fig. 16D; p=0.76], CB1 -/- mice spent
significantly more time immobile than CB1 +/+ mice [F(1,144)=18.9, p<0.001].
Significant interactions were observed for both latency to enter [F(9,144)=1.95,
p<0.05] and time immobile [F(9,144)=2.20, p<0.05]. In each case, post-hoc analysis
revealed significantly different values starting on acquisition day one (p<0.01).
Furthermore, significant differences on the final acquisition day suggest acquisition
deficits in CB1 -/- mice perseverate despite continued acquisition training.
Analysis of the first four acquisition trials on day one resulted in a similar pattern
of results. A significant effect of trial was observed for the latency to enter [Fig. 17B;
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F(3,48)=4.9, p<0.01], distance traveled [Fig. 17A; F(3,48)=10.8, p<0.0001], and adjusted
speed [fig. 17D; F(3,48)=3.9, p<0.05]. In contrast, no significant effect of trial on
immobility time was found [Fig. 17C; F(3,48)=2.0, p=0.11]. Again, CB1 -/- mice
required a greater amount of time to enter the goal box, resulting in a significant effect of
genotype [F(1,48)=14.1, p<0.01]. Notably, none of the CB1 -/- mice entered the goal box
on the first trial, likely contributing to the significant difference on day one, as shown in
fig. 17B. Despite similar performance on the first trial, the disparity in immobility time
between genotypes seen in the final three trials was sufficient to produce a significant
effect of genotype [F(1,48)=11.6, p<0.01]. Furthermore, control animals exhibited no
change in the amount of time spent immobile across trials, while CB1 -/- mice exhibited a
consistent increase in immobility, following the first trial. Finally, the genotypes did not
differ with regards to adjusted speed [F(1,48)=.35, p=0.55].
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Figure 16: CB1 -/- mice exhibit deficits in acquiring an aversively motivated Barnes
maze task. Distance (cm) traveled (panel A), and corresponding latency (s) to enter
(panel B) were significantly elevated in CB1 -/- mice compared to wild-type controls.
Panel C. A significant effect of genotype was observed for time immobile (s). Panel
D. No genotype differences were observed for adjusted speed [distance/(latency to
enter – total time immobile)]. * p<0.05 ** p<0.01 vs. the corresponding CB1 (+/+)
mice. The data for each acquisition session are represented as the average of four
daily trials ± SEM. N=9 mice/group.

94

Figure 17: CB1 -/- mice exhibit impaired acquisition on the first day of an aversively
motivated Barnes maze task. No genotype differences were observed for distance
(cm) traveled (panel A). Significantly greater latency (s) to enter (panel B) the goal
box, as well as time (s) spent immobile (panel C) were observed in CB1 -/- mice
compared to CB1 +/+ mice. The data are represented as the mean ± SEM. N=9
mice/group.
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CB1 -/- mice exhibit deficits in acquiring an appetitively conditioned Barnes maze task
Figure 18 A-D illustrate the primary dependent measures for acquisition of an
appetitively conditioned Barnes maze task across ten days of acquisition. A significant
effect of day was observed for distance [fig. 18A; F(9,126)=30.3, p<0.0001], latency to
enter [fig. 18B; F(9,126)=37.6, p<0.0001], time immobile [fig. 18C; F(9,126)=4.0,
p<0.0001], and adjusted speed [fig. 18D; F(9,126)=4.9, p<0.0001]; indicating both CB1 /- and CB1 +/+ mice acquired the task.
While both genotypes learned the task, significant genotype differences in
acquisition were observed for both latency to enter [F(1,126)=7.2, p<0.05], and distance
traveled [F(1,126)=8.9, p<0.01]. In both cases, CB1 -/- mice consistently traveled further,
and took more time to enter the escape box, than their wild-type littermates, illustrating
impaired acquisition of the task. In agreement with the aversive paradigm, genetic
deletion of the CB1 receptor resulted in a significant increased time immobile compared
to wild-type controls [F(1,126)=4.6, p<0.05]. Finally, analysis of adjusted speed revealed
a significant genotype by day interaction [F(9,126)=2.5, p<0.01]. However, post-hoc
analyses revealed that genotypes only differed significantly on days seven and nine
(p<0.05).
Unlike the aversive condition, analysis within the first acquisition day failed to
yield any significant genotype differences [distance: p=0.08 (Fig. 19A), latency to enter:
p=0.08 (Fig. 19B), time immobile: p=0.15 (Fig. 19C), adjusted speed: p=0.48 (Fig.
19D)]. Notably, mean values for all dependent measures on trial one were

96
indistinguishable between groups, suggesting significant differences across all ten
acquisition days were not confounded by differences in initial baseline performance.
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Figure 18: CB1 -/- mice exhibit impaired acquisition of an appetitively reinforced
Barnes maze task. Distance (cm) traveled (panel A), and corresponding latency (s) to
enter (panel B) were significantly elevated in CB1 -/- mice compared to wild-type
controls. Panel C. CB1 -/- spent significantly more time immobile (s) than their CB1
+/+ controls. Panel D. a significant genotype by day interaction was observed for
adjusted speed [distance/(latency to enter – total time immobile)]. * indicates a
significant difference from CB1 -/- mice. * p<0.05 The data for each acquisition
session are represented as the average of four daily trials ± SEM. N=8 mice/group.
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Figure 19: CB1 -/- mice acquire the Barnes maze task under appetitive conditions on
acquisition day one. The average distance (cm) traveled (panel A), and the
corresponding latency (s) to enter (panel B), did not significantly differ between
genotypes. Panel C. No genotype differences were observed for time immobile (s).
Panel D. Adjusted speed [distance/(latency to enter – time immobile)] did not differ
between genotypes. The data for each trial are represented as mean ± SEM. N=8
mice/group.

DISCUSSION

CB1 receptor -/- mice displayed impaired acquisition learning under both aversive
and appetitive conditions. These data suggest that acquisition deficits in CB1 -/- mice are
independent of the hedonic nature of the reinforcer. While we initially sought to evaluate
extinction learning in CB1 -/- mice as a complementary approach to previous studies
utilizing rimonabant, the impaired acquisition phenotype of CB1 -/- mice confounded
interpretation of results. Unlike previous reports investigating acquisition learning
following genetic deletion of the CB1 receptor, the procedure employed here utilized the
same behavioral demands (e.g. locating and entering the goal box) under varied
conditions of reinforcement (i.e. aversive and appetitive). Under both aversive and
appetitive conditions, CB1 +/+ mice exhibited acquisition learning on par with our
previous results, exhibiting a gradual decline in the latency to enter the goal box, as well
as a reduction in the concurrent distance traveled. Conversely, CB1 -/- mice displayed an
increased path length, and required more time to enter the goal box relative to their wildtype littermates. CB1 -/- mice exhibited impaired acquisition under both aversive and
appetitive conditions, suggesting that the behavioral demands of the task, and not the
source of reinforcement, are primarily responsible for the results presented here.
These data are in agreement with previous reports illustrating acquisition deficits
in CB1 -/- mice in aversively reinforced paradigms including contextual conditioned fear
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(Mikics et al., 2006), and delay eyeblink conditioning paradigms (Kishimoto and Kano,
2006). However, alternative paradigms dependent on aversive reinforcement have
exhibited enhanced, or intact acquisition performance. For example, CB1 -/- mice
exhibited enhanced acquisition in the active avoidance paradigm(Martin et al., 2002), as
well as social and object recognition tasks (Reibaud et al., 1999; Maccarrone et al., 2002;
Bilkei-Gorzo et al., 2005); and normal acquisition of spatial memory (Varvel and
Lichtman, 2002; Varvel et al., 2005), cued conditioned fear (Marsicano et al., 2002;
Cannich et al., 2004; Kamprath et al., 2006), and trace eyeblink conditioning (Kishimoto
and Kano, 2006). Conversely, in appetitively reinforced paradigms, CB1 -/- mice show
no impairment in acquiring operant conditioning (Bilkei-Gorzo et al., 2005; Holter et al.,
2005; Ward et al., 2007).
There are five possible explanations that may account for the lack of continuity in
the literature. First, the primary challenge in interpreting these data is the confounding
nature of comparing results across dissimilar behavioral paradigms. Differences in the
nature of reinforcement, as well as behavioral demands associated with qualitatively
different learning paradigms, preclude direct comparison across studies. For example,
previous reports utilizing appetitive reinforcement have relied on operant condition
paradigms, which have little in common with the behavioral demands of the Barnes maze
task. Ultimately, differences in procedural demands may be fundamental in unmasking
differences in acquisition performance between genotypes.
Second, exogenous administration of CB1 receptor agonists have been
demonstrated to increase the salience of food reward (Abel, 1975; Ward and Dykstra,
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2005). Concurrently, pharmacological or genetic attenuation of CB1 receptor signaling
has been demonstrated to decrease the salience and motivation for a diverse array of
palatable substances including high carbohydrate, high fat, and standard lab chow foodpellets (Verty et al., 2004; McLaughlin et al., 2006); sweet sucrose solutions (Arnone et
al., 1997; Higgs et al., 2003; Sanchis-Segura et al., 2004); the high-protein solution
Ensure® (Ward and Dykstra, 2005); and high-fat corn-oil (Ward and Dykstra, 2005).
Together, these reports illustrate the problematic nature of interpreting acquisition
performance following eCB manipulation, independent of changes in the hedonic value
of appetitive reward. In the current study, access to water within the goal box reinforced
acquisition learning in water-deprived subjects. As water consumption is unaffected by
manipulations of the eCB system (Arnone et al., 1997; Colombo et al., 1998; Poncelet et
al., 2003; Thanos et al., 2005) the results presented here are suggested as independent of
confounds related to changes in the hedonic value of the appetitive reward.
Third, the importance of controlling for age in CB1 -/- mice has been
underestimated until recently, and may also account for the lack of continuity among
results. Bilkei-Gorzo et al., (2005) were the first to report an accelerated age-related
decline in both cognitive performance and the density of hippocampal neurons, beginning
at three months of age. As subjects in the aversive paradigm were approximately twelve
to sixteen weeks of age, the aforementioned decline in cognitive performance may have
contributed to the impairment of acquisition learning. However, despite controlling for
age in the appetitive condition (i.e. subjects were six to eight weeks of age), acquisition
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deficits were still evident, suggesting that while age may exacerbate acquisition deficits,
it does not fully account for its occurrence.
Fourth, given the age-related decline in hippocampal morphology following CB1
receptor deletion, it is important to note that hippocampal injury is correlated with
impaired acquisition learning in the Barnes maze (Fox et al., 1998; Paylor et al., 2001;
Deacon and Rawlins, 2002; Raber et al., 2004) and other spatial memory tasks (Morris,
1984; Logue et al., 1997). Moreover, disruption of hippocampal function impairs
contextual fear conditioning (Phillips and LeDoux, 1992; Logue et al., 1997), and spatial
mapping (Sutherland et al., 1982). In contrast, damage to the hippocampus appears
independent of performance in cued spatial memory tasks (Morris, 1984; Fox et al.,
1998), as well as cued conditioned fear (Phillips and LeDoux, 1992; Logue et al., 1997).
Together, these reports underscore differences in substrate demands associated with
disparate learning tasks, and may contribute to the conflicting results presented here, and
those previously established.
Finally, in addition to disrupting acquisition of the Barnes maze task, genetic
attenuation of CB1 receptor signaling produced a significant increase in immobility time,
independent of the conditioning procedure. These data would suggest that processes
unrelated to learning and memory may be contributing to the observed acquisition
deficits. As the aversive paradigm is assumed to be more anxiogenic than the appetitive
paradigm, this hypothesis is further supported by the observation that all CB1 -/- mice
failed to enter the goal box on the first trial of day one in the aversive paradigm.
Importantly, the caveat that CB1 -/- mice failed to enter the goal box on the first trial
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because they found the Barnes maze less aversive than wild-type mice deserves attention.
However, this explanation appears unlikely as repeated Barnes maze exposures would
result in habituation to the stressful stimuli, gradually decreasing the anxiety provoked by
aversive stimuli. In turn, habituation to the stress of Barnes maze exposure would
increase the probability of electing not to enter the goal box in favor of remaining on the
maze. In contrast, both CB1 -/- and +/+ mice exhibited a reduction in the latency to enter
across successive trials.

Further supporting the hypothesis that processes unrelated to

learning may be responsible for the effects reported here is the report of similar
phenotypic differences in CB1 null mutant mice by Varvel & Lichtman (2002) in the
Morris water maze. Unlike wild-type controls, CB1 -/- mice were characterized by
labored motor behavior, a propensity for floating, seizures that ultimately resulted in
death, and the development of incompatible swim strategies (i.e. repetitive circling
behaviors). Ultimately, half of these mice were removed from the study for failing to
reach inclusion criteria. Similar methodological considerations designed to normalize
performance between genotypes have been reported, including increased food deprivation
(Holter et al., 2005), or comparison to baseline performance (Ward et al., 2007).
Together, the diversity in methodology, statistical transformations, and inclusion criteria
may play a primary role in determining whether anxiety-like behaviors are reported.
There is a growing body of literature supporting eCB modulation of stress and
anxiety. CB1 receptors expression occurs at different levels controlling the HPA axis,
such as the hippocampus and amygdala (Marsicano and Lutz, 1999; Mackie, 2005),
hypothalamus (Cota et al., 2003), the pituitary (Wenger et al., 1999), and adrenal glands
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(Galiegue et al., 1995). Administration of the CB1 receptor antagonist rimonabant dosedependently increases plasma corticosterone and ACTH (Manzanares et al., 1999; Wade
et al., 2006; Steiner et al., 2008), and is potentiated by restraint stress (Patel et al., 2004;
Steiner et al., 2008). In rats, chronic unpredictable stress significantly increases plasma
corticosterone, and reduces hippocampal, but not limbic forebrain, CB1 receptor protein
expression by 50% (Hill et al., 2005a). Similarly, CB1 -/- mice exhibit higher basal
levels of plasma corticoserone and ACTH (Barna et al., 2004; Cota et al., 2007; Steiner
et al., 2008), and hyper-responsiveness to stress (Barna et al., 2004; Steiner et al., 2008),
as well as CRH- and forskolin-induced ACTH secretion (Cota et al., 2007). While HPA
axis dysregulation in CB1 -/- mice has been postulated to arise from developmental
deficits (Wade et al., 2006), a recent report by Steiner et al., (2007) would suggest this is
not the case, as results in CB1 -/- mice were replicated following rimonabant
administration. Together, these reports, as well as the data presented here, support a role
of CB1 receptor signaling as a mechanism for dampening stress-induced corticosterone
secretion; independent of genetic background, type of stressor, or method of CB1 receptor
disruption (e.g. pharmacological vs. genetic). In relation to the present study, differences
in basal corticosterone secretion may contribute to the observed increase in immobility
time. Observationally, CB1 -/- mice spent an unusual amount of time immobile adjacent
to the goal box entrance prior to entering. This observation would explain for
consistently greater values for latency to enter and time immobile, and accounts for the
eventual asymptotic performance between genotypes with respect to distance traveled.
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However, anything beyond speculation warrants further elucidation of stress responses
following Barnes maze exposure.
The impact of chronic eCB disruption, either through cannabis use or
pharmacological antagonism, on cognition remains unclear. The results presented here
provide considerable evidence that long-term inactivation of eCB signaling disrupts both
aversively and appetitively reinforced acquisition learning. Furthermore, as the
qualitative behavioral demands of the task were unchanged between reinforcement
conditions, these data are the first to compare acquisition performance while controlling
for procedural differences. A notable caveat that remains undetermined is the possible
involvement of confounds related to genetic knockout mice, including genetic drift,
compensatory changes, and downstream developmental alterations (Taft et al., 2006).
These data are in conflict with previous results indicating that acquisition learning is
unaffected by pharmacological CB1 receptor antagonism. In fact, the only consistent
result between studies was increased immobility time in both aversively and appetitively
motivated procedures. The lack of continuity between studies would suggest that
impaired acquisition learning in CB1 -/- mice is a result of confounds associated with
gene deletion, or chronic attenuation of CB1 receptor signaling. To address this
uncertainty, future studies evaluating Barnes maze acquisition learning following chronic
administration of rimonabant are warranted. Nonetheless, these data raise the intriguing
possibility that chronic disruption of eCB signaling may ultimately take a substantial toll
on certain mnemonic processes.

EXPERIMENT 4

INTRODUCTION

The results of studies utilizing direct acting cannabinoid agonist administration
has contributed in a growing acceptance that the eCB system modulates cognitive
processes. However, confounds associated with exogenous CB1 agonist administration,
such as disruptive effects on motor behavior and memory, preclude the interpretation of
results as simulating endogenous activity (Pamplona and Takahashi, 2006). In contrast,
the recent availability of FAAH -/- mice (Cravatt et al., 2001), and FAAH inhibitors
provide an alternative approach to evaluate eCB function by inhibiting the metabolism of
the endocannabinoid anandamide, in effect magnifying and prolonging eCB signaling.
Already, a growing body of research would suggest FAAH inhibitors as a potential
pharmacotherapeutic with regards to disorders of depression (Gobbi et al., 2005; Naidu et
al., 2007), anxiety (Kathuria et al., 2003; Patel and Hillard, 2006; Naidu et al., 2007),
pain (Lichtman et al., 2004), and cognition (Varvel et al., 2006; Varvel et al., 2007).
The disruptive effects of exogenously administered CB1 agonists on acquisition
learning have been exhibited in rodents (Varvel et al., 2001) and humans (Chait and
Pierri, 1992). However, the impact of enhancing endogenous eCB signaling on cognitive
processes remains enigmatic. Varvel et al., (2006) were the first to report an
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enhancement of working memory in FAAH -/- mice during acquisition of the Morris
water maze spatial memory task. In this experiment, FAAH -/- mice displayed
accelerated acquisition rates compared to wild-type littermates. In a follow-up
experiment by the same group, FAAH -/- mice again exhibited enhanced acquisition, this
time of a fixed-platform task (Varvel et al, 2006). While these data suggest enhancing
eCB signaling facilitates acquisition learning, the lack of alternative studies in the
literature underscore the current inability to elucidate the conditions and extent to which
these effects are unmasked.
Procedural differences associated with disparate tasks, as well as the hedonic
nature of the reinforcer can determine the absence or expression of eCB modulated
cognitive effects. For example, the disruption of extinction learning following
rimonabant administration is primarily dependent on the nature of the reinforcer. As we
have shown, rimonabant disrupts extinction learning under aversive, but not appetitive
conditions. Conversely, CB1 -/- mice exhibit impaired acquisition of both aversive and
appetitively conditioned Barnes maze spatial learning. However, as these studies
evaluated attenuated CB1 receptor signaling, the extent to which these observations
generalize to enhanced eCB signaling remain unknown.
The present study utilized the Barnes maze procedure in which a variable source
of reinforcement (i.e. aversive or appetitive) motivates the acquisition of a consistent goal
(i.e. entering the goal box). Application of this new procedure presented the opportunity
to clarify the relative importance of procedural demands and hedonics, with regards to the
expression of genotypic differences in acquisition learning. The primary purpose of this
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experiment was to test the hypothesis that FAAH -/- mice would exhibit enhanced
acquisition under aversive, but not appetitive, conditioning procedures. Furthermore, we
postulated a CB1 receptor mechanism of action for enhanced acquisition in FAAH -/mice. To this end, a separate study was conducted in which FAAH -/- were administered
the CB1 receptor antagonist, rimonabant, or vehicle. As the same procedure was used,
differences were controlled and only the source of reinforcement was manipulated, we
sought to determine if the enhancement of acquisition learning observed in FAAH -/mice is dependent on the nature of the reinforcer.

METHODS

SUBJECTS

FAAH -/- mice (n=44) were derived from FAAH -/- congenic breeding pairs that
had been back-crossed onto a C57BL/6J background approximately 14 generations.
FAAH +/+ (n=32) mice used in the study were produced by FAAH +/+ parents derived
from a cross between a FAAH -/- congenic parent mated with a C57BL/6J from Jackson
labs. The resulting +/- offspring were then crossed with C57BL/6J mice to derive +/+
breeding pairs. All FAAH -/- and FAAH +/+ mice were bred from breeding pairs in
Virginia Commonwealth University (Lichtman et al., 2004). All subjects were housed in
a temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad
libitum access to food, and in the aversive condition, water. In the appetitive condition,
the same methodology as previously described was utilized. In short, subjects were
deprived of access to water for 22 h per day. Upon completion of acquisition trials,
subjects were allowed access to water for 2 h per day. All experiments have been
approved by the Institutional Animal Care and Use Committee at Virginia
Commonwealth University.
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PROCEDURE

Two types of testing conditions were used: aversive and appetitive. In the
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and
remained on during all stages and trials. In the appetitive procedure, a modified goal box
containing access to water was used as a reinforcer for water-deprived mice. Subjects
were given 22 h of daily water deprivation before each session and were weighed for
comparison to a pre-deprivation baseline. Immediately after each session, the mice were
returned to their home cages, given access to water for 2 h, and weighed.

Shaping
Shaping occurred as described previously. In summary, all subjects were
acclimated to the apparatus and basic procedure before formal acquisition training began.
The subject was placed in the start cylinder and released. Three min later, the subject
was placed in the goal box, which was then slid into one of the six corresponding target
locations. Following two min of acclimation to the goal box, the mouse was placed into
its home cage for a 30 s intertrial interval (ITI). After the ITI, the goal box was placed
back into its corresponding location and the subject was guided from the center of the
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maze to the entrance of the goal box. Shaping was concluded after at least two
consecutive entries into the goal box without provocation from the investigator.
Acquisition
Again, no deviations in acquisition procedure were employed. Each mouse was
given four acquisition trials per day for ten days. Each trial ended when either three min
had elapsed or the subject entered the goal box, whichever occurred first. In the event
that the mouse failed to enter the goal box within the three min trial, it was placed in the
center of the maze and the experimenter led it to the goal box where it remained for 30 s
before being returned to its home cage for the 30 s ITI. If the mouse repeatedly found the
goal box, but failed to enter, it was given additional shaping in which it was again placed
in the center of the maze and led to the escape hole, a process that was repeated until the
mouse entered the goal box without provocation from the experimenter. Acquisition
measures included test duration (latency to enter the hidden goal box), total time spent
immobile, distance traveled, and adjusted speed [distance/(latency to enter – time
immobile)].
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STASTICAL ANALYSES

AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate the
dependent measures of interest. As reported, measures of interest included adjusted
speed [distance traveled/(latency to enter – time immobile)], distance traveled, time spent
immobile, and latency to enter the goal box (test duration).
Results from comparison studies were analyzed using two-way mixed design
ANOVA (genotype by session). A significant effect of genotype was further analyzed
for each genotype condition by a one-way repeated measure ANOVA. Dunnett’s posthoc analysis with comparison to day one values was used when appropriate. Significant
interactions were analyzed in the same manner, but also included comparison of genotype
within each acquisition session using the Tukey post-hoc test.

RESULTS

FAAH -/- mice exhibit enhanced acquisition of an aversively conditioned Barnes maze
task

Under conditions of aversive reinforcement both FAAH -/- and +/+ mice acquired
the Barnes maze task, resulting in a significant effect of day for latency to enter [fig. 20B;
F(9,126)=35.2, p<0.0001], distance traveled [fig. 20A; F(9,126)=18.7, p<0.0001], time
immobile [fig. 20C; F(9,126)=3.5, p<0.001], and adjusted speed [fig. 20D;
F(9,126)=13.4, p<0.0001].
Comparison between genotypes resulted in a significant effect of latency to enter,
characterized by accelerated improvement in the task by FAAH -/- mice compared to
wild-type controls, resulting in both a significant effect of genotype [F(1,126)=22.2,
p<0.001] as well as a genotype by day interaction [F(9,126)=2.1, p<0.05]. While FAAH
-/- mice spent significantly less time immobile than FAAH +/+ mice, resulting in a
significant effect of genotype [F(1,126)=11.7, p<0.01], the FAAH -/- mice also showed
significantly higher mean running speed [F(1,126)=9.9, p<0.01] (data not shown), which
persisted when time immobile was accounted for (i.e. adjusted speed) [F(1,126)=9.7,
p<0.01].
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Analysis within the first day of acquisition resulted in a significant effect of trial
for duration [fig. 21B; F(3,42)=4.0, p<0.05], but not distance [fig. 21A; p=0.14], time
immobile [fig. 21C; p=0.19], or adjusted speed [fig. 21D; p=0.07].
No significant genotype effects were observed on the first acquisition day for all
measures [distance: p=0.13, time immobile: p=0.8, adjusted speed: p=0.15] with the
exception of latency to enter [F(1,42)=4.9, p<0.05]. Notably, genotype differences for
latency to enter were most prominent on trial three and four whereas on the first trial,
both genotypes exhibited similar starting latencies. The absence of any significant
genotype differences during the first trial would suggest that differences between
genotypes on day one in figure 20 are not confounded by learning that may have occurred
during shaping.
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Figure 20: FAAH -/- mice show enhanced acquisition of an aversive Barnes maze
procedure. No differences between genotypes were observed for distance (cm)
traveled (panel A), however, the corresponding average latency (s) to enter (panel B)
significantly differed between genotypes. FAAH -/- mice spent significantly less time
(s) immobile (panel C), and displayed a greater adjusted speed [distance/(latency to
enter – total time immobile)] compared to FAAH +/+ controls. * p<0.05 ** p<0.01
vs. FAAH -/- mice. The data for each acquisition session are represented as the
average of four daily trials ± SEM. * denotes a significant difference from FAAH -/mice. N=8 mice/group.
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Figure 21: FAAH -/- mice exhibit enhanced acquisition within the first acquisition
day of an aversive Barnes maze procedure. No genotype differences were observed
for distance (cm) traveled (panel A). Panel B. A significant genotype effect was
observed for latency (s) to enter the goal box with FAAH -/- acquiring the task faster
than wild-type controls. No genotype differences were observed for the amount of
time (s) spent immobile (panel C), or adjusted speed [distance/(latency to enter – time
immobile)]. All data are represented as mean ± SEM. N=8 mice/group.
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FAAH -/- mice display normalized acquisition under appetitive conditions
Under appetitive conditions, analysis of FAAH -/- and +/+ mice across ten days
of acquisition resulted in a significant effect of acquisition day for distance traveled [fig.
22A; F(9,162)=17.9, p<0.0001], latency to enter [fig. 22B; F(9,162)=41.3, p<0.0001],
time immobile [fig. 22C; F(9,162)=12.5, p<0.0001], and adjusted speed [fig. D;
F(9,162)=10.4, p<0.0001].
While these results illustrate the occurrence of acquisition learning, only time
immobile significantly differed between genotypes [F(1,162)=7.6, p<0.05]. In contrast to
the aversive paradigm, exposure to the appetitive condition increased the average amount
of time spent immobile in the FAAH -/- mice compared to FAAH +/+ controls.
However, no other genotype differences were observed (latency to enter: p=0.15, distance
traveled: p=0.40, adjusted speed: p=0.70).
Within the first acquisition day, a significant effect of trial was observed for
distance traveled [fig. 23A; F(3,54)=10.3, p<0.0001], latency to enter [fig. 23B;
F(3,54)=6.9, p<0.001], time immobile [fig. 23C; F(3,54)=2.9, p<0.05], and adjusted
speed [fig. 23D; F(3,54)=3.5, p<0.05]. However, no significant differences between
genotypes (latency to enter: p=0.10, distance traveled: p=0.77, time immobile: p=0.81,
adjusted speed: p=0.06), or genotype by day interactions, were observed, indicating that
performance was not affected by the shaping procedure.
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Figure 22: FAAH -/- mice show normal acquisition in an appetitively motivated
Barnes maze task. No genotype effects were observed for distance (cm) traveled
(panel A), or the corresponding latency (s) to enter the goal box (panel B). A
significant effect of genotype on the amount of time (s) spent immobile (panel C) was
observed. Panel D. Analysis of adjusted speed [distance/(latency to enter – time
immobile)] revealed no differences between genotypes. The data from each
acquisition session are represented as the average of four daily trials ± SEM. N=10
mice/group.
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Figure 23: FAAH -/- mice show normal acquisition of an appetitive Barnes maze
task, within the first day. No genotype effects were observed for distance (cm)
traveled (panel A), or the corresponding latency (s) to enter the goal box (panel B).
No differences were observed between genotypes based on time (s) spent immobile
(panel C), or adjusted speed [distance/(latency to enter – time immobile)]. All data are
represented as the average of each trial within the first acquisition day ± SEM. N=10
mice/group.
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Rimonabant (1mg/kg) Administration does not affect Barnes Maze Acquisition

Future experiments would utilize rimonabant to test the hypothesis that the
enhancement of acquisition, observed in FAAH -/- mice, is dependent on CB1 receptor
signaling. However, as a 3 mg/kg dose of rimonabant has been show to increase
immobility during acquisition of the Barnes maze task, characterization of a lower dose
was necessary to determine if similar effects would be elicited. A 1 mg/kg dose was
chosen as it has been shown to attenuate the behavioral effects of i.v. THC, without
producing locomotor disturbances when administered alone (Compton et al., 1996).
Administration of rimonabant or vehicle 30 min before exposure to the aversively
conditioned Barnes maze task did not affect acquisition learning, indicated by the
absence of significant treatment effects (Fig. 24A; distance: p=0.94; Fig 24B.; duration:
p=0.16; Fig. 24C; time immobile: p=0.16; Fig. 24D adjusted speed: p=0.36), or treatment
by day interactions (duration: p=0.59; distance: p=0.92; time immobile: p=0.29; adjusted
speed: p=0.57). Independent of treatment, the occurrence of acquisition learning was
denoted by a significant effect of acquisition day for all dependent measures, including
distance [F(2,20)=8.8, p<0.01], the corresponding latency to enter [F(2,20)=27.3,
p<0.0001], time immobile [F(2,20)=11.7, p<0.001], and adjusted speed [F(2,20)=8.2,
p<0.01].
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Figure 24: Rimonabant (1mg/kg i.p.) does not affect acquisition learning in an
aversively reinforced Barnes maze task. No differences were observed for distance
traveled, or the corresponding latency to enter the goal box. Panel C. Rimonabant
treatment does not affect the average time spent immobile. Panel D. No differences
were observed for adjusted speed [distance/(duration – time immobile)]. All data are
represented as the average of four daily trials ± SEM. N=6 mice/group.
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Rimonabant attenuates the enhancement of acquisition in FAAH -/- mice under aversive
conditions
To determine if genotype differences in acquisition were CB1 mediated, FAAH -/mice were administered either 1 mg/kg rimonabant or vehicle and compared to vehicleinjected FAAH +/+ controls. A significant effect of trial was observed for distance
traveled [fig. 25A; F(9,333)=61.6, p<0.0001], latency to enter [fig. 25B; F(9,333)=104.8,
p<0.0001], time immobile [fig. 25C; F(9,333)=10.7, p<0.0001], and adjusted speed [fig.
25D; F(9,333)=26.0, p<0.0001].
Comparison between groups failed to indicate differences in motor behavior
between groups, either for distance traveled [F(2,333)=1.6, p=0.21] or adjusted speed
[F(2,333)=1.4, p=0.25]. However, a significant group difference for latency to enter
[F(2,333)=3.6, p<0.05], as well as a group by day interaction [F(18,333)=1.7, p<0.05],
was observed. Post-hoc analysis indicated that FAAH -/- mice administered vehicle were
significantly different than FAAH -/- mice administered rimonabant (p<0.05). However,
comparison to respective day one values using Dunnett's test indicated that all groups
showed significant improvement (p<0.01) starting on day two.
Further differences were observed between groups when time spent immobile was
analyzed by repeated measures ANOVA. In this case, a significant effect of group
[F(2,333)=4.2, p<0.05] as well as a group by day interaction [F(18,333)=2.0, p<0.01]
were observed. Similar to duration, Tukey post-hoc analysis revealed a significant
difference between FAAH -/- mice administered rimonabant or vehicle. However, only
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FAAH -/- mice administered vehicle exhibited a significant (p<0.01) reduction in time
spent immobile by day 2, following Dunnett’s comparison to the first acquisition day.
Analysis within acquisition day one revealed a significant effect of trial for the
dependent measures distance [fig. 26A; F(3,111)=6.0, p<0.001], and latency to enter [fig.
26B; F(3,111)=3.6, p<0.05], but not time immobile (Fig. 26C, p=0.15) or adjusted speed
(Fig. 26D, p=0.71). No significant effects of group (duration: p=0.20; distance: p=0.44;
time immobile: p=0.15; adjusted speed: p=0.92), or group by trial interactions (duration:
p=0.86; distance: p=0.93; time immobile: p=0.39; adjusted speed: p=0.55), were
observed.
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Figure 25: Rimonabant administration (1 mg/kg) attenuates the enhancement of
acquisition in FAAH -/- mice under aversive conditions. Rimonabant or vehicle was
administered i.p. 30-min prior to testing on each acquisition day. No differences were
observed on distance (cm) traveled, however a significant effect of condition was
observed for the corresponding latency (s) to enter the goal box (panel B). A
significant effect of condition was also observed for time (s) spent immobile (panel
C). Panel D. Analysis of adjusted speed [distance/(latency to enter – time immobile)]
failed to reveal any significant differences between conditions. * indicates a
significant difference between FAAH -/- + RIM and FAAH -/- + Vehicle groups. *
p<0.05. All data are represented as the average of four daily trials ± SEM. N= 13-14
mice/condition.
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Figure 26: Rimonabant (1 mg/kg) does not affect acquisition in FAAH -/- mice
within the first acquisition day of an aversively conditioned Barnes maze task.
Rimonabant or vehicle was administered i.p. 30-min prior to the first acquisition trial.
No differences between conditions were observed for distance (cm) traveled (panel
A), or the corresponding latency (s) to enter the goal box (panel B). Panel C. No
differences were observed for time immobile (s). Panel D. Adjusted speed
[distance/(latency to enter – time immobile)] failed to yield any significant differences
between conditions. All data are represented as the average of each trial ± SEM.
N=13-14 mice/condition.

DISCUSSION

FAAH -/- mice exhibited enhanced acquisition learning in an aversive, but not an
appetitive, Barnes maze task. These data support the hypothesis that stimulating eCB
signaling enhances acquisition of an aversively reinforced spatial memory task (Varvel et
al., 2007). Furthermore, as the behavioral demands (i.e. locating and entering the goal
box) remained unchanged between reinforcement conditions, to our knowledge this is the
first report to illustrate the enhancement of acquisition following FAAH deletion as
dependent on reinforcement conditions. The data also extend the hypothesis that the eCB
system mediates extinction learning under aversive conditions, but is dispensable for
appetitively-motivated learning (Holter et al., 2005) to include acquisition learning.
While we initially proposed evaluating extinction learning, FAAH +/+ mice failed to
exhibit decreased perseverant behavior in the target zone, confounding interpretation of
results.
During initial acquisition sessions in the aversive paradigm, FAAH -/- mice
required less time than their wild-type counterparts to achieve the goal of the task,
entering the hidden goal box. A similar pattern of results was observed within the first
acquisition day, as FAAH -/- mice required less time to enter the goal box, resulting in a
significant effect of genotype. As both genotypes exhibited similar latencies within the
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first trial, the observed effects are independent of learning that may have occurred during
shaping. Importantly, the CB1 receptor antagonist rimonabant attenuated the
enhancement, indicating the effects were specific to the FAA anandamide. In the
appetitive conditioning procedures, no differences between genotypes were observed
with regards to the latency to enter the goal box. Consequently, the aforementioned
effects on acquisition learning are specific to aversive conditions.
An unexpected finding in these experiments was that the adjusted speed under
aversive conditions of the FAAH -/- mice was significantly quicker than for the FAAH
+/+ mice, suggesting that the decreased escape latencies in the FAAH -/- mice can be
accounted by differences in motor behavior, and is further supported by the observation
that genotypes did not differ in the distance traveled to complete the task. While initial
reports utilizing exogenous administration of AEA have shown a hypomotile response,
(Crawley et al., 1993; Fride and Mechoulam, 1993; Smith et al., 1994) it is generally
accepted that this approach does not mimic endogenous function given AEA’s short halflife in vivo (i.e. <5 min.) (Willoughby et al., 1997). In contrast, inhibition of FAAH
provides an alternative approach by inhibiting the metabolism of endogenously released
anandamide, in effect magnifying and prolonging the physiological response. Genetic
and pharmacological approaches to FAAH inhibition have suggested motor behavior is
unaffected in the open-field test (Cravatt et al., 2001; Cippitelli et al., 2007; Moreira et
al., 2008), and elevated plus maze (Naidu et al., 2007). Conversely, in the fixed platform
Morris water maze (Varvel et al., 2007) paradigm, the authors report a significant
increase in swim speed in FAAH -/- mice, as well as enhanced acquisition. Similar to the
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aversive conditioning Barnes maze paradigm, the methodology employed in the Morris
water maze utilized aversive reinforcement to motivate learning a fixed goal location in a
spatial memory task (Morris, 1982). Thus, aversive reinforcement appears to be
necessary to unmask genotype differences in motor behavior and/or acquisition of spatial
memory.
Alternatively, the enhancement of acquisition presented here may reflect
alterations in emotionality and attentional processes. Specifically, pharmacological
inhibitors of FAAH have been reported to produce an anxiolytic response in several
murine models of emotionality (Kathuria et al., 2003; Viveros et al., 2005; Bortolato et
al., 2006; Patel and Hillard, 2006; Naidu et al., 2007). Likewise, both pharmacological
and genetic attenuation of eCB signaling have been shown to produce anxiogenesis
(Navarro et al., 1997; Arevalo et al., 2001; Haller et al., 2002; Maccarrone et al., 2002;
Martin et al., 2002; Rodgers et al., 2005; Patel and Hillard, 2006). As we have shown
previously, CB1 -/- mice spend more time immobile and exhibit acquisition deficits when
exposed to the aversively conditioned Barnes maze paradigm, supporting the initial
hypothesis that heightened emotionality contributes to the disruption of spatial memory
learning (Ferrari et al., 1999). Furthermore, as FAAH -/- mice spent significantly less
time immobile, and acquired the task faster than controls the results, the data would
suggest the eCB system facilitates learning under aversive conditions by dampening the
expression of anxiety.
In contrast to the results from the aversive paradigm, FAAH -/- mice spent
significantly more time immobile than controls in the appetitive conditioning procedure.
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As eCB’s are presumed to be released on demand in response to aversive stimuli (Di
Marzo et al., 1994; Marsicano et al., 2002; Marsicano et al., 2003; Piomelli, 2003;
Hohmann et al., 2005), it is possible that the conditions associated with the appetitive
paradigm are insufficient to increase eCB signaling. However, this explanation does not
account for the increase in immobility time under the appetitive conditioning procedure.
However, it deserves mentioning that immobility is a very complex phenotype and may
result from multiple factors in addition to freezing, including fear and arousal.
Alternatively, the rewarding value of escaping an aversive situation may be
enhanced in FAAH -/- mice. Evidence suggesting the endocannabinoid and
dopaminergic systems work in tandem to activate reward processes is further supported
by observations that increase FAAH inhibition increases motivation for ethanol and food
consumption (Giuffrida et al., 1999; De Vries et al., 2001; Di Marzo et al., 2001;
Blednov et al., 2007; Soria-Gomez et al., 2007). However, these observations do not
adequately account for the observation that FAAH -/- mice spend significantly more time
immobile under appetitive conditions. Instead, compensatory changes associated with
genetic FAAH deletion may account for these observations. Given that only the source
of reinforcement was altered in the present experiment, differences in hedonics between
the aversive and appetitive paradigm would appear to be of primary importance. For
example, uncharacterized alterations in hedonics associated water deprivation, or water
consumption, might occur following genetic manipulation. However, the latter
explanation appears insufficient as FAAH -/- mice show a preference for water
containing ethanol, but not sucrose or quinine, in the two-bottle choice paradigm
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(Basavarajappa et al., 2006; Blednov et al., 2007). Thus, it appears future experiments
are required to elucidate possible genotype differences in motivation following water
deprivation.
As FAAH is primarily responsible for the metabolism of many FAAs (i.e. AEA,
oleamide, PEA, and OEA) (Cravatt et al., 1996), we used rimonabant to determine
whether the phenotypic acceleration in acquisition was CB1 receptor mediated. Indeed,
rimonabant normalized acquisition learning in FAAH -/- mice to the same rate as FAAH
+/+ mice, implicating a CB1 receptor mechanism of action, as well as the involvement of
the only FAAH substrate with relevant cannabinoid activity, anandamide. Of interest,
rimonabant treatment increased the amount of time spent immobile in FAAH -/- mice to
levels indistinguishable from vehicle treated controls, providing evidence that FAAH -/mice display a CB1 receptor mediated anxiolytic response to aversive conditions.
Importantly, we have shown that the dose of rimonabant used in the current experiment
(1 mg/kg) does not affect Barnes maze performance.
In conclusion, the results provided here provide evidence that the eCB system
modulates acquisition under aversive conditions, but is dispensable for appetitivelymotivated learning. Furthermore, these data suggest FAAH inhibitors be useful as an
alternative pharmacotherapy in treating anxiety disorders. Currently, the most
predominant pharmacological treatment remains GABA agonists, which are
characterized by generalized anxiolysis and side-effects such as learning and memory
disruptions, and abuse liability. In contrast, FAAH inhibitors appear to exert their
anxiolytic properties under specific conditions such as exposure to aversive conditions
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(Naidu et al., 2007), lack side-effects associated with cannabinoid agonists (Lichtman et
al., 2004), and facilitate certain mnemonic processes.

GENERAL SUMMARY

The data presented here support the following conclusions: 1) Mice acquire, and
extinguish the Barnes maze task under both appetitive and aversive conditions of
reinforcement, 2) Rimonabant does not impair the acquisition of either an appetitively or
aversively conditioned Barnes maze task, 3) Rimonabant disrupts extinction learning of
an aversive, but not an appetitive, Barnes maze task, 4) Extinction learning is
independent of forgetting, 5) Compared to CB1 +/+ mice, CB1 -/- mice exhibit deficits in
acquiring both an aversive and appetitive Barnes maze task, and 6) FAAH -/- mice
acquire an aversively, but not appetitively, conditioned Barnes maze task faster than
FAAH +/+ controls.
The initial objective of these studies was to develop, and characterize, a paradigm
in which the source of reinforcement varied, and the goal of the task remained constant.
To this end, we adapted the Barnes maze task (Barnes, 1979) so that bright lights and air
turbulence motivated learning under aversive conditions, and access to water reinforced
learning under appetitive conditions. Importantly, previous research has demonstrated
that alterations in eCB signaling can affect a subject’s motivation to work for palatable
food (De Vry and Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), but does
not alter water consumption (Arnone et al., 1997; Colombo et al., 1998; Poncelet et al.,
2003; Thanos et al., 2005). As subsequent studies focused on manipulations to the
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endogenous cannabinoid system, we departed from the use of palatable food reward in
favor of access to water under appetitive conditions.
We evaluated three conditioning procedures in the Barnes maze task: appetitive,
aversive, and ambient. In the aversive condition, bright lights and air turbulence
motivated learning the task. Conversely, in the appetitive condition, subjects were water
deprived and the goal box was modified to provide access to water. Finally, conditions
common to both the aversive and appetitive procedure (i.e., no bright lights, air
turbulence, or water deprivation) were utilized for the ambient conditioning paradigm.
Subjects in each condition displayed normal acquisition learning, exhibiting gradual
improvement in their ability to complete the task, based on the latency and distance
traveled to enter the hidden goal box. Under conditions common to both the appetitive
and aversive conditions, subjects in the ambient conditioning group consistently traveled
further, spent more time immobile, and took longer than their aversively or appetitively
conditioned counterparts. These findings suggest that the added source of motivation,
either aversive or appetitive, accelerate and improve acquisition of the Barnes maze task.
In addition, the results also suggest that Barnes maze exposure is sufficient to motivate
learning the task, possibly through an innate aversion to open fields, or the intrinsic
reward value of the goal box.
During extinction of the task, the goal box was removed and subjects in each
condition were given a three min probe trial, and the percentage of time spent in the
target zone, the zone which was formerly associated with the goal box, was used as a
measure of extinction learning. Subjects in all three reinforcement conditions
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extinguished the task, exhibiting a gradual reduction in the percentage of time in the
target zone following repeated exposures to the Barnes maze. Importantly, a control
experiment was performed to distinguish forgetting from extinction learning. In this
experiment, subjects were divided into two groups following acquisition. While the first
group (Group Extinction) received their first nine extinction trials, the second group
(Group No Extinction) remained in the vivarium. On the tenth and final extinction trial
for Group Extinction, both groups were evaluated. While Group Extinction exhibited a
significant reduction in time spent in the target zone, Group No Extinction exhibited a
preference for the target zone, indistinguishable from Group Extinctions first trial. These
results support the conclusion that mice extinguished the behavior, and did not merely
forget the escape box location.
Having characterized Barnes maze acquisition and extinction learning under
qualitatively different conditioning procedures, we tested the hypothesis that rimonabant
would disrupt extinction learning under aversive, but not appetitive, conditions. The
hypothesis that rimonabant is dispensable for appetitively, but not aversively conditioned
extinction learning, was first proposed by Holter et al., (2005) and recently supported by
Niyuhire et al., (2007). In both reports, attenuated CB1 receptor signaling, either
pharmacological or genetic, did not significantly impair extinction of operant tasks. In
contrast, rimonabant and genetic deletion of the CB1 receptor disrupts extinction learning
in a number of aversively reinforced procedures (Marsicano et al., 2002; Suzuki et al.,
2004; Varvel et al., 2005; Kamprath et al., 2006; Niyuhire et al., 2007). However, the
validity of the hypothesis by Holter et al., (2005) remains undetermined due in part to the
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difficulty of reconciling between differences in hedonics and behavioral demands of
disparate tasks. Specifically, behavioral demands required by operant tasks (i.e. learning
to press a lever for food reward) are qualitatively different from the Morris water maze
(i.e. learning to locate and swim to a hidden platform) or conditioned freezing (i.e.
learning a tone is predictive of a shock). Furthermore, the experiments by Holter et al.,
and Niyuhire et al., utilized palatable food reward to reinforce operant learning. As
discussed, genetic and pharmacological antagonism of CB1 receptor signaling decreases
the salience of food reward (Ward and Dykstra, 2005), as well as palatable sucrose
solution (Higgs et al., 2003), and reduces operant responding for food (De Vry and
Jentzsch, 2004; Holter et al., 2005; Ward et al., 2007). To address these outstanding
issues, we evaluated extinction learning in a Barnes maze task utilizing consistent
behavioral demands, with a varying source of reinforcement.
Rimonabant treatment disrupted extinction learning under aversive, but not
appetitive conditions. These data strongly support the hypothesis that the
endocannabinoid system mediates learning under aversive conditions, but is dispensable
for appetitively-motivated learning (Holter et al., 2005). Unlike previous reports, this
study represents the first case in which the same behavioral demands were required (i.e.
locating and entering the goal box) and only the source of reinforcement was varied.
Control mice trained in either the aversive or appetitive Barnes maze conditioning
paradigms showed a gradual decline in the percentage of time spent in the target zone
across the extinction trials. Conversely, rimonabant-treated mice trained in the aversive
conditioning procedure spent significantly more time in the zone that previously
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contained the escape box than each of the other zones. In contrast, in the appetitive task,
rimonabant-treated mice showed a virtually identical decrease in the percentage of time
spent in the target zone as vehicle-treated mice.
Rimonabant did not impair acquisition of either the aversively, or appetitively,
conditioned Barnes maze task, exhibiting similar latencies and path lengths to enter the
goal box across acquisition trials compared to vehicle-treated subjects. However,
rimonabant administration resulted in significantly more time spent immobile than
vehicle treated mice under both conditions of reinforcement. It is possible that the
increased immobility time is an anxiogenic effect of rimonabant administration, as
supported by the observation that rimonabant dose-dependently increases plasma
corticosterone (Patel et al., 2004; Wade et al., 2006; Steiner et al., 2008). However,
future experiments are necessary to determine the validity of this hypothesis.
Our second objective was to characterize acquisition performance of CB1 -/- mice
in both the aversively and appetitively conditioned Barnes maze tasks. Genetic deletion
of the CB1 receptor produces a variety of learning effects which appear dependent on
procedure. For example, CB1 -/- mice exhibit enhanced acquisition of recognition
memory in the object (Reibaud et al., 1999; Maccarrone et al., 2002) and social
recognition paradigms (Bilkei-Gorzo et al., 2005); impaired acquisition of contextual
conditioned fear and delay eyeblink conditioning (Kishimoto and Kano, 2006; Mikics et
al., 2006); and normal acquisition of spatial memory (Varvel and Lichtman, 2002; Varvel
et al., 2005), cued conditioned fear (Marsicano et al., 2002; Cannich et al., 2004;
Kamprath et al., 2006), operant conditioning tasks (Bilkei-Gorzo et al., 2005; Holter et

137
al., 2005; Ward et al., 2007), and trace eyeblink conditioning (Kishimoto and Kano,
2006). However, results from appetitively reinforced operant paradigms are difficult to
interpret due to confounds related to age, the choice of appetitive reinforcer, and
inclusion criteria. Specifically, Bilkei-Gorzo et al., (2005) were the first to report an
accelerated age-related decline in both cognitive performance and the density of
hippocampal neurons, beginning at three months of age. The age of subjects from the
studies by Ward et al., and Holter et al., utilized mice corresponded with the age-related
deficits reported by Bilkei-Gorzo et al., possibly affecting results. Furthermore,
methodological considerations designed to normalize performance between genotypes
have been reported, including increased food deprivation in CB1 -/- mice (Holter et al.,
2005), comparison to baseline performance (Ward et al., 2007), and the exclusion of
subjects for exhibiting strange behavior or failing to reach criteria (Varvel et al., 2005;
Ward et al., 2007). To address these concerns, we utilized young, age-matched CB1 -/and +/+ mice, departed from food reward in favor of access to water, and excluded
acquisition criteria to test the hypothesis that CB1 -/- would exhibit impaired acquisition
independent of reinforcement condition.
CB1 -/- mice exhibited impaired acquisition of both the aversively and
appetitively conditioned Barnes maze task compared to CB1 +/+ controls. Independent of
reinforcement condition, CB1 -/- mice traveled further, and required more time to achieve
the goal of the Barnes maze task across acquisition trials. Furthermore, CB1 -/- mice
consistently spent more time immobile than their wild-type counterparts. Of interest,
both genotypes achieved asymptotic performance for only one of the aforementioned
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dependent variables, distance traveled. The observation that CB1 -/- mice tended to travel
to the goal box entrance, and remained immobile for a variable interval prior to entering,
may account for the consistently greater latency to enter and amount of time spent
immobile. Analysis of the first four trials of acquisition day one in the aversively
conditioned paradigm revealed that the CB1 -/- mice had significantly longer latencies to
enter the goal box, and increased time immobile compared to CB1 +/+ mice. Conversely,
no significant differences were found during analysis of the first four trials of the
appetitively conditioned task.
We initially attempted to assess extinction learning in CB1 -/- mice to provide a
complementary approach to studies utilizing the pharmacological CB1 antagonist
rimonabant. However, acquisition deficits in CB1 -/- mice confounded the possible
interpretation of extinction results. Regardless, these reports support the hypothesis that
disparate acquisition results previously reported between CB1 -/- and +/+ mice are due to
differences in behavioral demands of qualitatively dissimilar tasks, rather than the
hedonic nature of reinforcement. Furthermore, two explanations may account for the
observed differences between genotypes in the results garnered from the present
experiments. First, CB1 receptor deletion may impair critical aspects of acquisition
learning, though the exact mechanisms (i.e. neuronal or behavioral) remain
undetermined. Alternatively, the act of entering the goal box may be inherently, and
insurmountably, more aversive in CB1 -/- mice. This explanation is supported by
consistently greater latencies to enter the goal box, as well as the observation that CB1 -/tended to remain immobile adjacent to the escape hole prior to entering.
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The purpose of our final objective was to characterize acquisition learning in a
genetic model of enhanced eCB signaling. To this end, FAAH -/- and +/+ mice were
evaluated in both the aversively and appetitively conditioned Barnes maze task.
Currently, only two reports have been published evaluating acquisition performance in
FAAH -/- mice. In both cases, FAAH -/- mice exhibited enhanced acquisition of the
Morris water maze task compared to FAAH +/+ controls (Varvel et al., 2006; Varvel et
al., 2007). However, it is unknown whether these results generalize to alternative
memory models. The Barnes maze task allowed us to evaluate two outstanding questions
in relation to the works by Varvel et al., (2006, 2007). First, would FAAH -/- mice
exhibit enhanced acquisition in an alternative spatial memory paradigm with qualitatively
different behavioral demands? Second, is the enhancement of acquisition dependent on
the conditioning procedure (i.e. aversive or appetitive)? Thus, we evaluated the
hypothesis that FAAH -/- mice will exhibit enhanced acquisition of the Barnes maze task
under both appetitive and aversive conditioning procedures.
FAAH -/- mice acquired the task faster than their +/+ counterparts in an
aversively, but not an appetitively, conditioned Barnes maze task. In relation to the work
by Varvel et al., (2006, 2007) the present data suggest that enhanced acquisition of
FAAH -/- mice are not limited by qualitatively different behavioral responses demanded
by dissimilar spatial memory paradigms. Under aversive conditions, FAAH -/- mice
required less time to complete the task for the initial six days of acquisition, after which
time both genotypes exhibited asymptotic performance. However, no genotype
differences were observed for the total distance traveled. FAAH -/- mice also spent
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significantly less time immobile, and traveled faster than FAAH +/+ mice. As the
measure ‘adjusted speed’ corrects for differences in immobility time, it is possible that
FAAH -/- mice are better at performing the Barnes maze task because they run faster.
This alternative explanation is supported by results from the dependent measure distance
traveled, considered a more objective measure of learning than latency to enter, as no
genotype differences were observed.
Conversely, under the appetitive conditioning procedure, FAAH -/- and +/+ mice
did not significantly differ in adjusted speed, the total distance traveled, or corresponding
latency to enter the goal box. In contrast with results from the aversively conditioned
paradigm, FAAH -/- spent more time immobile than +/+ mice. One possible explanation
for the conflicting results is the hypothesis that endocannabinoids are released under
aversive conditions. If true, this would suggest that any aversiveness inherent to the
appetitively conditioned paradigm, such as being exposed to an open area, is not
sufficient to increase eCB signaling. However, this explanation appears insufficient as it
cannot account for the increase in immobility time observed in FAAH -/- mice under
appetitive conditions. Alternatively, compensatory changes associated with genetic
deletion of FAAH may explain the increase in immobility time. Regardless, immobility
is a very complex phenotype and could be due to many different reasons in addition to
freezing.
Our final experiment tested the hypothesis that FAAH -/- mice exhibited
enhanced acquisition through a CB1 mediated mechanism of action. Inhibition of the
FAAH enzyme results in significantly elevated levels of anandamide, as well as non-
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cannabinoid FAAs (Cravatt et al., 2001). Among the non-cannabinoid FAAs are the
sleep-inducing compound oleamide (OLE; Cravatt et al., 1995), the anti-inflammatory Npalmitoylethanolamine (PEA; Lambert et al., 2002), and the appetite suppressing agent
N-oleoylethanolamine (OEA; Rodriguez de Fonseca et al., 2002). Anandamide is also an
endogenous agonist at the TRPV1 receptor (zygmunt et al, 1999; Smart et al., 2000; Van
der Stelt & DiMarzo, 2004). The heat-activated TRPV1 receptor was first identified by
its responsiveness to the compound capsaicin, isolated from hot chili peppers, and is
purported to mediate responses to thermal and chemical pain (Caterina et al., 1997;
Szallasi & Blumberg, 1999). The purpose of this experiment was to determine if nonspecific cannabinoid mechanisms were responsible for the enhanced acquisition observed
in FAAH -/- mice. To this end, we used rimonabant to test the hypothesis that CB1
antagonism attenuates the enhancement of acquisition observed in FAAH -/- mice.
Rimonabant (1 mg/kg) administration in FAAH -/- mice resulted in performance
indistinguishable from FAAH +/+ mice. These results support the hypothesis that
enhanced acquisition in FAAH -/- mice is mediated through a CB1 receptor dependent
mechanism of action. Furthermore, the results support the exclusion of non-cannabinoid
FAAs as mediating acquisition effects in FAAH -/- mice. In this experiment, we
evaluated three groups: FAAH -/- mice receiving rimonabant, FAAH -/- mice
administered vehicle, and FAAH +/+ mice administered vehicle. Importantly, we
utilized a dose of rimonabant (1 mg/kg) which we determined did not affect Barnes maze
performance. In agreement with previous results, the total distance traveled did not
significantly differ between groups. Furthermore, FAAH -/- mice administered vehicle
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exhibited consistently lower values for the latency to enter the goal box, as well as
immobility time. As these effects were absence in FAAH -/- mice administered
rimonabant, the results support a cannabinoid mechanism of action. Finally, departing
from previous observations, analysis of adjusted speed failed to reveal any significant
differences between groups. The conflicting adjusted speed results, between this study
and the initial study comparing genotypes, are perplexing as the only difference in
experimental procedure was the administration of drug or vehicle; suggesting the effect is
either related to nonspecific effects associated with i.p. injection or an artifact resulting
from unknown differences in cohorts.

GENERAL DISCUSSION

We have identified three alternative explanations for the failure of rimonabant to
disrupt extinction learning under appetitive conditions. First, reduced motivation might
result in a concomitant reduction in the performance, resulting in faster extinction.
However, this does not appear likely as we observed asymptotic acquisition performance
between appetitive and aversive conditioning procedures during methods development.
Furthermore, control mice in the aversive condition exhibited a more robust decline in the
percentage of time spent in the target zone during extinction trials when compared to
control animals in the appetitive condition. Second, cognitive impairments resulting
from water deprivation may potentially contribute to weaker memory formation and
faster extinction. Again, this possibility is unlikely because both conditions displayed
similar acquisition performance. A third possibility is the eCB system is differentially
involved in extinction, depending on the nature of reinforcement during extinction
training, rather than during acquisition. For example, extinction learning in classical
conditioning models is reinforced by the omission of punishment, and can be regarded as
rewarding. Operant conditioning models, however, bear aspects of frustration as they
rely on the omission of reward. In the present experiment, the source of reinforcement
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between conditions involved a similar aspect, omission of the goal box. As rimonabant
disrupted extinction learning in one condition, but not the other, it would appear that the
results cannot be attributed to the involvement of eCB signaling in reward processes
during extinction learning.
The results presented here are grounded in the assumption that learning, either
under the aversive or appetitive conditioning procedure, is motivated primarily by
representative stimuli for each condition (i.e., bright lights and air turbulence for aversive
procedures vs. access to water in appetitive procedures). This assumption is supported by
the observation that additional reinforcement, either aversive or appetitive, improved
acquisition performance when compared to ambient reinforcement conditions. These
data also suggest that exposure to the Barnes maze is sufficiently aversive to motivate
mice to escape an elevated, open field. Alternatively, the goal box could be sufficiently
rewarding or merely preferable to the maze.
Water deprivation may be inherently aversive, producing a state of prolonged
stress that result in untoward compensatory changes. Rodents, like most animals, have
evolved distinct physiological mechanisms enabling them to adapt to prolonged periods
in which food or water may be unavailable. As a result, it has been hypothesized rodents
are equipped to handle dehydration periods for as long as 24 h without any overt signs of
physiological stress or behavioral abnormalities (Rowland, 2007). Among these adaptive
mechanisms, is a reduction in food intake in the absence of access to water, resulting in
‘dehydration anorexia’ (Watts, 1999). Thus, there is potential for water-deprivation to
produce a concomitant, food-deprived state. However, in a study using rats subjected to
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a dehydration paradigm, in which water was replaced with hypertonic saline, no
alterations in feeding were observed until the second day of deprivation, suggesting a
relatively slow onset of dehydration anorexia. Furthermore, the authors reported a rapid
reversal of anorexia within the first 30 min of free access to water (Watts, 1999). As we
have shown, mice subjected to our water restriction protocol quickly adapt to the
procedure and are able to maintain their body weight appropriately. Together, these
results would support the observation by Rowland (2007) that rodents are able to entrain
their ingestive responses to adapt to availability. Water deprivation may also cause
alterations in stress hormones. However, in rats subjected to 48 h of water-deprivation, a
slight but significant elevation in basal corticosterone, but not ACTH was observed. In
response to 15 min of restraint stress, no differences between water-deprived and control
animals was observed for corticosterone levels, and ACTH levels decreased (Aguilera et
al., 1993). Furthermore, in a study where rats were restricted to 15 min access to water
per day, no changes were observed with regards to open-field behavior, freezing
behavior, or corticosterone levels. In contrast, food-restriction to 80% baseline weight
resulted in significantly greater activity in the open-field, and higher mean serum
corticosterone (Heiderstadt et al., 1999). While these results suggest that water
restriction produces a negligible stress response, it is unknown whether adaptations occur
with regards to the eCB system. Thus, future studies designed to evaluate possible
changes, such as CB1 receptor density or eCB content, deserve consideration.
A growing body of research has implicated the endogenous cannabinoid system
as modulating homeostatic mechanisms related to neuroendocrine responses to stress and
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energy balance, and manifested as anxiety (Pagotto et al., 2006; Tasker, 2006). The
primary response to a stressor is activation of the hypothalamic-pituitary-adrenocortical
(HPA) axis, and subsequent increase in plasma corticosterone. Co-localization of CB1
receptors at each level controlling HPA axis functioning has been shown, suggesting a
multi-tiered role for eCB modulation of the stress response (Galiegue et al., 1995;
Marsicano and Lutz, 1999; Wenger et al., 1999; Pagotto et al., 2001; Cota et al., 2003;
Mackie, 2005). In support, rimonabant dose-dependently increases basal and stressedinduced plasma corticosterone secretion (Patel et al., 2004; Wade et al., 2006; Steiner et
al., 2008). Concurrently, CB1 -/- mice exhibit increased plasma corticosterone secretion
in response to stress (Haller et al., 2002; Barna et al., 2004), and at rest (Barna et al.,
2004; Cota et al., 2007; Steiner et al., 2008). Behaviorally, CB1 -/- mice exhibit an
aggressive, and anxiety-like phenotype (Navarro et al., 1997; Martin et al., 2002), which
may result from compensatory mechanisms associated with a life-long absence of CB1
receptors (Wade et al., 2006). Indeed, chronic exposure to unpredictable stress results in
adaptive changes in the hippocampus, including a 50% reduction in CB1 receptor density,
and a 40% reduction in 2-AG content (Hill et al., 2005b). In contrast to attenuated CB1
receptor signaling, enhancement of eCB signaling appears to dampen the stress response.
Acute presentation of anxiogenic stimuli increases 2-AG and AEA content in the
amygdala (Marsicano et al., 2002; Patel et al., 2004). Administration of the FAAH
inhibitors AM-404 or URB-597 both decrease plasma corticosterone in response to
restraint stress (Patel et al., 2004), and FAAH -/- mice and URB-treated rodents exhibit
anxiolytic-like effects (Kathuria et al., 2003; Patel and Hillard, 2006; Naidu et al., 2007).
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There is evidence that the intensity of a stressor can impair or facilitate memory
acquisition, and exhibits a U-shaped curve (McGaugh, 1985; Korneyev, 1997). Mild,
low-intensity stressors, such as handling or exposure to an intruder, appear to stimulate
cognitive function and facilitate acquisition (Shors et al., 1992). In contrast, severe
stressors such as inescapable shock inhibit memory formation in rodents (Anderson and
Paden, 1966; Jackson et al., 1980), and humans (Pitman, 1989). One particular brainregion exhibiting marked sensitivity to stress-induced alterations is the hippocampus.
Specifically, dendritic atrophy and decrements in long-term potentiation have been
reported following chronic exposure to stress (Galea et al., 1997; Alfarez et al., 2003). In
rodent models of cognition, these physiological changes appear to result in impairments
of acquisition and reversal/extinction learning (Luine et al., 1993; Luine et al., 1994;
Francis et al., 1995; de Quervain et al., 1998; Vasconcellos et al., 2003; Hill et al.,
2005b). Collectively, these reports suggest that eCB manipulations can affect cognitive
processes by altering responding to stress, or vice versa. In relation to the present work,
it is difficult to distinguish the extent to which, if any, alterations in the physiological
response to stress influence performance. For example, the deficits in acquisition
associated with CB1 -/- mice may be a result of a hyperresponsiveness to the stress of
open-field exposure, deficits in cognitive processes such as consolidation, or both. In
addition, motor deficits associated with CB1 receptor deletion, such as reduced bone
density in CB1 -/- mice on the C57 background , may result in poorer performance
compared to CB1 +/+ mice (Tam et al., 2006). The observation that CB1 -/- mice, and
rimonabant-treated mice, consistently spent more time immobile than controls, supports
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the involvement of eCB-mediated alterations in anxiety during acquisition of the task.
Furthermore, in the aversive paradigm, FAAH -/- mice spent significantly less time
immobile than FAAH +/+ mice. Together, these results suggest that under aversive
conditions, the eCB system is actively engaged in dampening the stress response elicited
by aversive conditions. However, acquisition was only affected in CB1 -/- and FAAH -/mice, and rimonabant did not impair acquisition of the task under either reinforcement
condition. Thus, compensatory mechanisms associated with genetic deletion of the
FAAH enzyme or CB1 receptor may be responsible for the alterations in acquisition
learning. Finally, it is unclear why FAAH -/- spent significantly less time immobile
under aversive conditions, but spent significantly more time immobile under appetitive
conditions. However, mobility is a complicated phenotype and is affected by a wide
range of factors including but not limited to fear and arousal. As endocannabinoids are
released on demand in response to stressors, it is tempting to speculate that appetitive
conditions are insufficient to cause eCB release. The resulting increase in eCB signaling
under aversive conditions would produce an anxiolytic response, and is supported by the
observation that subthreshold doses of THC produce anxiolytic-like effects (Valjent et
al., 2002).
Comparing initial day one baseline acquisition data across studies reveals
differences in initial acquisition performance between experiments. However, as we
treated each experiment as a separate entity, no analyses were performed comparing data
between experiments. Furthermore, these differences appear to be specific to individual
experiments. For example, comparing acquisition data from the first day of the appetitive

149
procedure (i.e. methods development and rimonabant during acquisition) reveals slightly
different values. However, in each case within group means and standard errors appear
consistent, suggesting differences do not arise from distinct populations of ‘fast’ and/or
‘slow’ learning subjects. Regardless, we assume that these differences are an artifact
produced by different cohorts of subjects, and do not affect the interpretation of the data.
It is unknown whether rimonabant will disrupt extinction learning in the
appetitive task if administered during both acquisition and extinction. In the aversive
paradigm, rimonabant was administered during acquisition and extinction in one
experiment, and only during extinction in a follow-up experiment. However, in the
appetitive model, rimonabant administration only occurred during extinction. While we
assumed from results in the aversive paradigm that administration of rimonabant during
extinction is sufficient to disrupt extinction learning, the application of this conclusion to
the appetitive condition deserves consideration.
There are three uncertainties regarding the data presented here that could be
clarified in future studies. First, it is unknown whether exposure to the Barnes maze task
results in HPA axis activation. Experiments designed to collect and measure plasma
corticosterone at different time-points during acquisition, after handling, and at rest,
would provide a framework for future experiments, as well as characterize the
physiological consequence of acute and repeated Barnes maze exposure in relation to
stress as well as associated adaptive changes in the stress response. Alternatively, if the
effects observed during acquisition reflect altered anxiety, supporting evidence may be
procured via administration of a sub-threshold dose of a benzodiazepine. Of course a
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dose-response curve would be necessary as benzodiazepines have well-document
amnesic effects.
Second, experiments designed to characterize eCB content in relevant brain areas
such as the hippocampus, amygdala, and PFC, would facilitate our understanding of how
the eCB system responds to acute and repeated exposure to the aversive and appetitive
Barnes maze task, and later, may aid the identification of purported adaptive changes
associated with genetic deletion of the FAAH enzyme. Alternatively, complementary
approaches to manipulate the eCB system, aside from pharmacological drug
administration, would provide convergent data for results from genetic knockouts. For
example, siRNA specific for CB1 or FAAH would create an acute genetic knockout with
transient effects. Thus, this approach would aid the distinction between effects associated
with genetic inhibition, or adaptive changes resulting from the life-long absence of a
gene.
Third, attentional processes can affect performance during cognitive tasks,
resulting in altered performance. In the present context, it is unknown whether our
observations result from abnormal attention to the context stimuli, rather than the task
itself. Future experiments utilizing a cued procedure, in which a salient proximal cue
demarcates the location of the hidden goal, will allow us to demonstrate whether a deficit
in acquisition occurs with preserved general attention, motoric abilities, and motivation
(Whishaw and Tomie, 1987). For example, septal lesions result in impaired acquisition
of the homing board, and Morris water maze, resulting in longer latencies and path
lengths to find the hidden goal (Kelsey and Landry, 1988; Brandner and Schenk, 1998).
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Following the introduction of a salient cue, the deficits in acquisition were reversed,
suggesting deficits in reference memory. Introduction of the same methodology into the
Barnes maze model would provide information regarding the nature of the acquisition
effects reported here. In the case of our CB1 -/- mice acquisition data, it appears unlikely
that the deficits result from shifted attention to aversive stimuli, as the deficits were also
observed in the absence of bright lights and air turbulence. However, as mentioned, a
cued procedure would also facilitate investigation into altered motor processes, or
motivation. As differences in running speed were observed in FAAH -/- mice, the
necessity of running a cued procedure is underscored.
Endocannabinoid-based pharmacotherapies to treat a wide range of disorders are
under development. As research in the field of endocannabinoids progresses, so does the
evidence for pharmacotherapeutic potential. Already, manipulations of this system hold
potential for therapies in the fields of pain, inflammation, obesity, drug abuse, diabetes,
anxiety, depression, and cognitive disorders. The results presented here further support
the hypothesis that the endocannabinoid system mediates the extinction of behaviors that
are specific to aversive conditions, leaving extinction of learned behaviors in appetitively
reinforced tasks intact. While it remains questionable whether the physiological role of
the endocannabinoid system is involved in other forms of positively reinforced (e.g.,
sexual) learning, the system’s impact on aversively motivated learning is unmistakable.
These results underscore the importance of understanding a patient’s history prior to
administering rimonabant or other cannabinoid receptor antagonists should they become
therapeutically available. Specifically, contraindication might include patients with a
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history that includes abuse or traumatic events (e.g. combat, criminal assault, severe
injury) that interfere with normal, daily functioning. For example, post-traumatic stress
disorder has been described as a failure of extinction learning (Rothbaum & Davis,
2003). Treatment of a patient suffering from post-traumatic stress disorder, or similar
afflictions (e.g. panic attacks, obsessive-compulsive disorder, and adjustment disorder)
would be difficult, if not impossible, following rimonabant administration. Furthermore,
administering a drug that interferes with normal extinction learning, such as rimonabant,
might exacerbate such an illness.
In contrast to the potential harm associated with rimonabant administration, and
possibly CB1 antagonism in general, these results have an encouraging aspect. First, the
results suggest that therapies resulting in increased endocannabinoid signaling, as with a
FAAH inhibitor or a cannabinoid receptor agonist, may accelerate extinction learning,
thereby presenting a potential therapeutic treatment for psychiatric disorders that are
hypothesized to include elements of maladaptive cognitive processes and an inability to
adapt to a new environment (i.e., post-traumatic stress disorder [PTSD], phobias, and
generalized anxiety disorder [GAD]) (Lutz, 2007). In general, these disorders result from
unpleasant prior experiences, are manifested as feelings of intense anxiety and panic, and
persist due to inappropriate extinction (Milad et al., 2006). Recently, Varvel et al.,
(2006) reported that FAAH -/- mice, and mice administered the FAAH inhibitor OL-135,
displayed accelerated extinction learning in the Morris water maze, further underscoring
the therapeutic potential of endocannabinoid based drugs.
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Goal of the
Task
Descend into
escape box

Number of Holes

Author

18

(Barnes, 1979)

Source of
Motivation
Bright lights

Descend into
escape box

40

(Bach et al.,
1995)

Bright lights,
tone

Mice

Evaluate CaMKII
-/- mice

Descend into
escape box

40

(Fox et al.,
1998)

Bright lights

Mice

CCI induced
cognitive deficits

Descend into
escape box

16

(Pompl et al.,
1999)

Bright lights/fan

Mice

Descend into
escape box

40

(Inman-Wood et
al., 2000)

Mice

Descend into
escape box

12

(Miyakawa et
al., 2001)

Bright
lights/fan/tone;
all turned off
after completion
of goal
Unknown

Assess APPsw
mice in a new
model
Prenatal exposure
to cocaine

Descend into
escape box

12

(Grootendorst et
al., 2001)

Return to homecage, sugar in
home-cage

Species
Rats

Experimental
Purpose
Evaluate
senescence

Mice

Evaluation of Ng
-/- mice

Mice

Stress and ApoE
-/- mice

Dependent measures
latency to enter,
speed, strategy,
distance, total errors,
angle of deviation
Total errors, strategy,
distance from tunnel,
perseverative errors,
Latency to enter,
strategy - % of trials
used, total errors
latency to enter, total
errors, error scale
Total errors, latency
to enter, strategy, # of
holes from target hole
Latency to find,
distance to find, total
errors, time
spent/hole, speed.
Latency to find,
velocity, distance, %
time per zone (center,
mid, tunnel, outer
ring), strategy, total
pokes
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Goal of the
Task
Descend into
escape box

Number of Holes

Source of
Motivation
Bright lights

36

(Paylor et al.,
2001)

Mice

Descend into
escape box

12

(Holmes et al.,
2002)

Bright lights (?)

Mice

Behavioral
profiles of inbred
strains

Descend into
escape box

30

(Williams et al.,
2003)

Rats

Prenatal meth
exposure

Walk into
escape tunnel

12

(Koopmans et
al., 2003)

fruit loop in goal
box or bright
lights
Escape tunnel
allows access to
home cage

Mice

strain differences
in new model

Descend into
escape box

40

(Seeger et al.,
2004)

Bright lights,
tone

Mice

Evaluation of M2
-/- mice

Descend into
escape box
Descend into
escape box
(same as
Pompl et al.)

40

(Dawood et al.,
2004)
(Bredy et al.,
2004)

Unknown

Mice

Bright lights/fan

Mice

(Raber et al.,
2004)

Bright lights,
tone

Mice

Compare training
paradigms
neonatal
handling/paternal
care in
monogamous
mice
Radiation
induced cognitive
deficits

Descend into
escape box

16

40

Author

Species

Experimental
Purpose
LHX5 -/- mice

Dependent measures
Latency to find,
composite search
score, composite
search score, site
errors
Errors to reach target,
target hole preference
index, speed, distance,
Visits/hole, speed,
distance
latency to first hole,
latency to find target
hole, total errors
Latency to enter,
distance to find, total
errors, speed, time in
target zone
Latency to enter, total
errors, latency to
enter, # perseverations
latency to find, total
errors prior to finding,
Latency to find , total
errors prior to finding,
time in target zone,
target hole approaches
Errors, distance from
escape hole, strategy
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Goal of the
Task
Descend into
escape box

Number of Holes

Author

Source of
Motivation
Gentle handling

Species

12

(Harrison et al.,
2006)

Descend into
escape box

20

(Barr et al.,
2007)

Buzzer (80dB),
bright lights.

Mice

Evaluation of
ApoER2 -/- mice.

Descend into
escape box

40

(Dai et al.,
2007)

Bright lights

Mice

Descend into
escape box

40

(Hong et al.,
2007)

Fans, bright
light.

Mice

Cognitive
dysfunction in
H1 and H2 -/mice.
Assess Emx1 -/mice

Descend into
escape box

24

(Mueller and
Bale, 2007)

Bright lights
and/or air
turbulence
and/or 100 dB
noise

Mice

Mice

Experimental
Purpose
Spatial and nonspatial search
strategies in the
Barnes maze

Prenatal stress on
learning
performance

Dependent measures
Errors prior to
finding, latency to
find, distance to find,
total errors, latency to
enter, total distance,
strategy - % of trials
used, % time in target
zone
Latency to find,
errors, perseverations,
distance from first
hole investigated to
target hole, total
errors, latency to
enter.
Distance to enter.

Path-length, velocity,
latency to find
Latency to first hole,
distance of first hole
searched to target
hole, errors, latency to
find, errors after
finding, search
strategy, success.
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Goal of the
Task
Descend into
escape box

Number of Holes

Author

19

(O'Connor et
al., 2007)

Descend into
escape box

20

(O'Tuathaigh et
al., 2007)

Descend into
escape box

20

(Prut et al.,
2007)

Descend into
escape box

12

Descend into
escape box

Descend into
escape box

Source of
Motivation
Bright lights,
aversive
auditory
stimulus

Species
rats

Experimental
Purpose
Effects of
progesterone
following
traumatic brain
injury.
Assess NRG1 -/mice

Litter from
home cage and
Honey Loops
(food reward) in
escape box.
Bright Lights.
Buzzer (80dB),
bright lights.

Mice

Mice

Assess APP23 -/mice

(Reiserer et al.,
2007)

Gentle handling

Mice

Assess APPsw -/mice

40

(Rueda-Orozco
et al., 2007)

White noise
(90dB), bright
lights

Rats

Endocannabinoid
mediation of
search strategy

18

(Simola et al.,
2008)

Unknown

Rats

Assess perinatal
asphyxia in nonspatial memory.

Dependent measures
Latency to enter

Latency to enter,
distance traveled,
number of errors

Latency to enter,
number of errors,
search strategy
omission errors,
errors/distance/latency
to find, total errors,
strategy - % of trials
used, % time in target
zone
Total errors, % search
strategy, mean time of
performance, % errors
in target zone, median
of the distance.
Latency to find, total
errors.
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Goal of the
Task
Descend into
escape box

Number of Holes

Author

Source of
Motivation
Bright lights

30

(Vorhees et al.,
2007)

Descend into
escape box

8

(Xu et al., 2007)

Descend into
escape box.

12

(Ambree et al.,
2007)

Descend into
escape box

16

(Fabricius et al.,
2008)

Bright lights,
loud rock and
techno music.

Mice

Descend into
escape box.

40

(Fedorova et al.,
2007)

Bright lights.

Mice

Descend into
escape tunnel

12

(Moreau et al.,
2008)

Tunnel leading
to homecage

Mice

Ambient
laboratory
conditions
Bright lights

Species
Rats

Mice
Mice

Experimental
Purpose
Developmental
effects of
MDMA on
spatial learning.
Assess age
differences in TgSwDI -/- mice
L-DA in murine
models of
Alzheimer’s
(TgCRND8 -/mice).
Maternal
separation on
behavior and
hippocampal
neuronal count.
Spatial learning
following n-3
fatty acid
deficient diet.
Behavioral
effects of p75Saporin
immunotoxin.

Dependent measures
Latency to find,
distance to find, total
distance traveled.
Latency to find the
escape hold
Path length, latency to
find, latency to enter,
% time in target zone.
Latency to find,
distance traveled,
error frequency, visits
to target hole and
adjacent two holes,
search strategy.
Distance, latency to
enter, number of
errors, total time
mobile/immobile.
Visits to target/nontarget holes, latency to
find, order of visited
holes, repetitive
errors.
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Goal of the
Task
Descend into
escape box

Number of Holes

Author

Source of
Motivation
Bright lights

Species

20

(Oliveira et al.,
2008)

Descend into
escape tunnel

12

(Richter et al.,
2008)

Tunnel leading
to homecage,
bright lights

Mice

Descend into
escape box

8(?)

(Trofimiuk and
Braszko, 2008)

Unknown

Rats

Rats

Experimental
Purpose
Involvement of
polyamine
binding sights at
NMDAr in
creatine-induced
spatial learning
enhancement.
Assess
TgCRND8 -/mice in enriched
environment.
Alleviation of
stress induced
spatial memory
impairments with
St. Johns wort.

Dependent measures
Latency to find, total
errors.

Path length, latency to
enter, time spent in
target zone.
Latency to find, total
errors.
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EDUCATION
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Dissertation: “Endocannabinoid Modulation of Spatial Memory.”
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April 2008

March 2007

May 2003

RESEARCH EXPERIENCE
Graduate Research Assistant
Department of Pharmacology and Toxicology, School of Medicine
Virginia Commonwealth University, Richmond, Virginia
Mentor: Aron H. Lichtman.

2003-2008

Undergraduate Research Assistant
Department of Psychology, Furman University,
Mentor: Judith E. Grisel

2002-2003

PUBLICATIONS AND PAPERS
Wilson DM, Varvel SA, Harloe JP, Martin BR, Lichtman AH. “SR 141716 (Rimonabant) Precipitates Withdrawal
in Marijuana-Dependent Mice.” Pharmacol. Biochem. Behav. 2006. 85(1):105-113.
Harloe JP, Thorpe AJ, Lichtman AH. “Differential Endocannabinoid Regulation of Extinction in Appetitive and
Aversive Barnes Maze Tasks.” Under Review at Neuropsychopharmacology.
Harloe JP, Lichtman AH. “Alterations in Endocannabinoid Signaling Produce Disparate Acquisition Profiles in an
Aversive and Appetitive Barnes Maze Task.” Manuscript in Preparation.

ABSTRACTS/SCIENTIFIC PRESENTATIONS
Harloe JP, Lichtman AH. “Rimonabant Disrupts Extinction in an Aversive, but not an Appetitive Barnes Maze
Task.” Watts Day Symposium. Richmond, VA. Poster. 2007.
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Harloe JP, Lichtman, AH. “Rimonabant Disrupts Extinction in an Aversive, but not an Appetitive Barnes Maze
Task.” Carolina Cannabinoid Collaborative. Wilmington, NC. Poster. 2007.
Harloe JP, Lichtman AH. “Rimonabant Disrupts Extinction in an Aversive, but not an Appetitive Barnes Maze
Task.” International Cannabinoid Research Society. Quebec, Canada. Poster. 2007.
Harloe JP, Thorpe AJ, Lichtman AH. “SR-141716, the CB1 Antagonist, Impairs Extinction In the Barnes Maze
Paradigm.” Central Virginia Chapter Society for Neuroscience. Richmond, VA. Poster. 2006.
Harloe JP, Thorpe AJ, Lichtman AH. “SR-141716, the CB1 Antagonist, Impairs Extinction In the Barnes Maze
Paradigm.” Society for Neuroscience. Atlanta, GA. Poster. 2006.
Harloe JP. “Modulation of Learning and Memory by the Endocannabinoid System.” Dept. of Pharmacology &
Toxicology Student Seminar. Richmond VA. 2006.
Harloe JP. “Cannabinoids and Memory in the Barnes Maze Paradigm.” Dept. of Pharmacology & Toxicology
Student Seminar. Richmond, VA. 2006.
Harloe JP, Grisel JE. “Sex-Dependent Effects of Melanocyte Stimulating Hormone (MSH) on Social Interaction.”
Dept. of Psychology Research & Internship Forum. Greenville, SC. Poster. 2003.
Harloe JP, Grisel JE. “Sex-Dependent Effects of Melanocyte Stimulating Hormone (MSH) on Social Interaction”
Nat. Conf. Undergrad. Research. Salt Lake City, UT. Poster. 2003.

AWARDS
Travel Award, International Cannabinoid Research Society, Quebec, Canada
Furman Advantage Research Fellowship, Furman University, Greenville SC
Travel Award, National Conference of Undergraduate Research, Salt Lake City, UT

2007
2002
January 2002

TEACHING EXPERIENCE
Virginia Commonwealth University, Richmond, Virginia - Questers
Lab Leader
Organized, prepared, and implemented curriculum for high school science
students.

6/2005, 06, 07

INSTITUTIONAL SERVICE
VCU Student Government Association
Departmental Representative
Acted as liaison between the school and our department, Honor Council
alternate
Pharmacology & Toxicology Student Government Organization
Student Representative
Organized and planned departmental functions and activities.

2005-2007

2005-2007

MEMBERSHIPS
Society for Neuroscience
International Cannabinoid Research Society
Carolina Cannabinoid Collaborative

SKILLS
Proficient in experimental models of anxiety, depression, memory, pain, and drug abuse.
Extensive knowledge of electronics, as well as computer hardware and software

2006-present
2006-present
2006-present

